CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: pyridoindole
Accession: CHEBI:48888
browse the term
Synonyms: related_synonym: pyridoindoles
G
Ahr
aryl hydrocarbon receptor
increases expression
ISO
2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of AHR protein
CTD
PMID:27644595
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression multiple interactions
EXP ISO
2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A1 mRNA; 2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A1 protein lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A1 mRNA]; lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A1 protein]
CTD
PMID:8902619 PMID:27644595
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression multiple interactions
EXP ISO
2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 mRNA; 2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 protein lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 mRNA]; lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 protein] CYP1A2 protein results in increased activity of and results in increased hydroxylation of 2-amino-3-methyl-9H-pyrido(2,3-b)indole; CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 2-amino-3-methyl-9H-pyrido(2,3-b)indole
CTD
PMID:8902619 PMID:14729582 PMID:27644595 PMID:28160022
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
Ddc
dopa decarboxylase
decreases activity
ISO
2-amino-3-methyl-9H-pyrido(2,3-b)indole results in decreased activity of DDC protein
CTD
PMID:2243617
NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806
G
H2ax
H2A.X variant histone
increases expression
ISO
2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of H2AX protein modified form
CTD
PMID:28160022
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
G
Nat2
N-acetyltransferase 2
increases activity multiple interactions
ISO
NAT2 protein results in increased activity of 2-amino-3-methyl-9H-pyrido(2,3-b)indole NAT2 protein results in increased metabolism of and results in increased susceptibility to 2-amino-3-methyl-9H-pyrido(2,3-b)indole
CTD
PMID:14729582 PMID:28160022
NCBI chr16:26,974,874...27,005,191
Ensembl chr16:26,974,601...26,976,304
G
Slc22a2
solute carrier family 22 member 2
multiple interactions decreases activity
ISO
2-amino-3-methyl-9H-pyrido(2,3-b)indole inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] 2-amino-3-methyl-9H-pyrido(2,3-b)indole results in decreased activity of SLC22A2 protein
CTD
PMID:30189235
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
G
Sult1a1
sulfotransferase family 1A member 1
multiple interactions
ISO
SULT1A1 protein results in increased activity of and results in increased sulfation of 2-amino-3-methyl-9H-pyrido(2,3-b)indole; SULT1A1 protein results in increased metabolism of and results in increased susceptibility to 2-amino-3-methyl-9H-pyrido(2,3-b)indole
CTD
PMID:14729582 PMID:28160022
NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131
G
Sult1b1
sulfotransferase family 1B member 1
increases activity
ISO
SULT1B1 protein results in increased activity of 2-amino-3-methyl-9H-pyrido(2,3-b)indole
CTD
PMID:14729582
NCBI chr14:20,771,917...20,784,665
Ensembl chr14:20,771,868...20,785,549
G
Sult1c2a
sulfotransferase family 1C member 2A
increases activity
ISO
SULT1C2 protein results in increased activity of 2-amino-3-methyl-9H-pyrido(2,3-b)indole
CTD
PMID:14729582
NCBI chr 9:7,075,873...7,103,316
Ensembl chr 9:7,066,905...7,244,132
G
Ahr
aryl hydrocarbon receptor
increases expression
ISO
2-amino-9H-pyrido(2,3-b)indole results in increased expression of AHR protein
CTD
PMID:27644595
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression
EXP ISO
CYP1A1 protein results in increased metabolism of and results in increased activity of 2-amino-9H-pyrido(2,3-b)indole 2-amino-9H-pyrido(2,3-b)indole results in increased expression of CYP1A1 mRNA
CTD
PMID:1913651 PMID:27644595
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions increases expression
ISO EXP
[CYP1A2 protein co-treated with NAT2 gene polymorphism] promotes the reaction [2-amino-9H-pyrido(2,3-b)indole binds to and results in increased mutagenesis of HPRT1 gene]; [furafylline results in decreased activity of CYP1A2 protein] which results in decreased susceptibility to 2-amino-9H-pyrido(2,3-b)indole; CYP1A2 protein results in increased metabolism of and results in increased activity of 2-amino-9H-pyrido(2,3-b)indole; CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 2-amino-9H-pyrido(2,3-b)indole 2-amino-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 mRNA
CTD
PMID:1913651 PMID:19243127 PMID:23898916 PMID:27644595 PMID:28160022
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
H2ax
H2A.X variant histone
increases expression
ISO
2-amino-9H-pyrido(2,3-b)indole results in increased expression of H2AX protein modified form
CTD
PMID:28160022
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
multiple interactions
ISO
[CYP1A2 protein co-treated with NAT2 gene polymorphism] promotes the reaction [2-amino-9H-pyrido(2,3-b)indole binds to and results in increased mutagenesis of HPRT1 gene]
CTD
PMID:19243127
NCBI chr X:137,655,744...137,687,718
Ensembl chr X:137,655,680...137,687,712
G
Nat2
N-acetyltransferase 2
multiple interactions affects response to substance
ISO
[CYP1A2 protein co-treated with NAT2 gene polymorphism] promotes the reaction [2-amino-9H-pyrido(2,3-b)indole binds to and results in increased mutagenesis of HPRT1 gene]; NAT2 protein results in increased metabolism of and results in increased susceptibility to 2-amino-9H-pyrido(2,3-b)indole NAT2 gene polymorphism affects the susceptibility to 2-amino-9H-pyrido(2,3-b)indole
CTD
PMID:19243127 PMID:28160022
NCBI chr16:26,974,874...27,005,191
Ensembl chr16:26,974,601...26,976,304
G
Por
cytochrome p450 oxidoreductase
multiple interactions
ISO
POR gene mutant form results in decreased metabolism of and results in increased susceptibility to 2-amino-9H-pyrido(2,3-b)indole
CTD
PMID:26583703
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809
G
Slc22a2
solute carrier family 22 member 2
decreases activity multiple interactions
ISO
2-amino-9H-pyrido(2,3-b)indole results in decreased activity of SLC22A2 protein 2-amino-9H-pyrido(2,3-b)indole inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]
CTD
PMID:30189235
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
G
Slc22a8
solute carrier family 22 member 8
multiple interactions decreases activity
ISO
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine promotes the reaction [2-amino-9H-pyrido(2,3-b)indole inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]]; 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine promotes the reaction [2-amino-9H-pyrido(2,3-b)indole results in decreased activity of SLC22A8 protein]; 2-amino-9H-pyrido(2,3-b)indole inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; 2-amino-9H-pyrido(2,3-b)indole promotes the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]]; 2-amino-9H-pyrido(2,3-b)indole promotes the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased activity of SLC22A8 protein]
CTD
PMID:28629854
NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588
G
Sult1a1
sulfotransferase family 1A member 1
multiple interactions
ISO
SULT1A1 protein results in increased metabolism of and results in increased susceptibility to 2-amino-9H-pyrido(2,3-b)indole
CTD
PMID:28160022
NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131
G
Ahr
aryl hydrocarbon receptor
increases expression
ISO
3-amino-1-methyl-5H-pyrido(4,3-b)indole results in increased expression of AHR protein
CTD
PMID:27644595
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
G
Alb
albumin
multiple interactions
ISO
MPO protein promotes the reaction [3-amino-1-methyl-5H-pyrido(4,3-b)indole binds to ALB protein]
CTD
PMID:6254679
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
3-amino-1-methyl-5H-pyrido(4,3-b)indole results in increased expression of CYP1A1 mRNA
CTD
PMID:27644595
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
affects response to substance multiple interactions increases expression affects metabolic processing increases activity
ISO
CYP1A2 protein affects the susceptibility to 3-amino-1-methyl-5H-pyrido(4,3-b)indole CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 3-amino-1-methyl-5H-pyrido(4,3-b)indole 3-amino-1-methyl-5H-pyrido(4,3-b)indole results in increased expression of CYP1A2 mRNA CYP1A2 protein affects the metabolism of 3-amino-1-methyl-5H-pyrido(4,3-b)indole 3-amino-1-methyl-5H-pyrido(4,3-b)indole results in increased activity of CYP1A2 protein
CTD
PMID:2655891 PMID:12744663 PMID:19140158 PMID:27644595 PMID:28160022
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
Ddc
dopa decarboxylase
decreases activity
ISO EXP
3-amino-1-methyl-5H-pyrido(4,3-b)indole results in decreased activity of DDC protein
CTD
PMID:2243617 PMID:2904812
NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806
G
H2ax
H2A.X variant histone
increases expression
ISO
3-amino-1-methyl-5H-pyrido(4,3-b)indole results in increased expression of H2AX protein modified form
CTD
PMID:28160022
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
increases mutagenesis
ISO
3-amino-1-methyl-5H-pyrido(4,3-b)indole results in increased mutagenesis of HPRT1 gene
CTD
PMID:2335011
NCBI chr X:137,655,744...137,687,718
Ensembl chr X:137,655,680...137,687,712
G
Maoa
monoamine oxidase A
decreases activity
ISO
3-amino-1-methyl-5H-pyrido(4,3-b)indole results in decreased activity of MAOA protein
CTD
PMID:3404091
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
G
Mpo
myeloperoxidase
multiple interactions
ISO
MPO protein promotes the reaction [3-amino-1-methyl-5H-pyrido(4,3-b)indole binds to ALB protein]
CTD
PMID:6254679
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
G
Nat2
N-acetyltransferase 2
multiple interactions
ISO
NAT2 protein results in increased metabolism of and results in increased susceptibility to 3-amino-1-methyl-5H-pyrido(4,3-b)indole
CTD
PMID:28160022
NCBI chr16:26,974,874...27,005,191
Ensembl chr16:26,974,601...26,976,304
G
Por
cytochrome p450 oxidoreductase
multiple interactions decreases activity
ISO
3-amino-1-methyl-5H-pyrido(4,3-b)indole promotes the reaction [purpurin anthraquinone results in increased activity of POR protein] 3-amino-1-methyl-5H-pyrido(4,3-b)indole results in decreased activity of POR protein
CTD
PMID:12744663
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809
G
Slc22a1
solute carrier family 22 member 1
decreases activity multiple interactions
ISO
3-amino-1-methyl-5H-pyrido(4,3-b)indole results in decreased activity of SLC22A1 protein 3-amino-1-methyl-5H-pyrido(4,3-b)indole inhibits the reaction [SLC22A1 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]; 3-amino-1-methyl-5H-pyrido(4,3-b)indole inhibits the reaction [SLC22A1 protein results in increased import of Tetraethylammonium]
CTD
PMID:30189235
NCBI chr 1:50,624,339...50,651,437
Ensembl chr 1:50,624,377...50,651,436
G
Slc22a2
solute carrier family 22 member 2
decreases activity multiple interactions
ISO
3-amino-1-methyl-5H-pyrido(4,3-b)indole results in decreased activity of SLC22A2 protein 3-amino-1-methyl-5H-pyrido(4,3-b)indole inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]; 3-amino-1-methyl-5H-pyrido(4,3-b)indole inhibits the reaction [SLC22A2 protein results in increased import of Tetraethylammonium]
CTD
PMID:30189235
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
G
Slc22a3
solute carrier family 22 member 3
multiple interactions decreases activity
ISO
3-amino-1-methyl-5H-pyrido(4,3-b)indole inhibits the reaction [SLC22A3 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] 3-amino-1-methyl-5H-pyrido(4,3-b)indole results in decreased activity of SLC22A3 protein
CTD
PMID:30189235
NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:50,783,218...50,872,353
G
Slc22a8
solute carrier family 22 member 8
decreases activity multiple interactions
ISO
3-amino-1-methyl-5H-pyrido(4,3-b)indole results in decreased activity of SLC22A8 protein 3-amino-1-methyl-5H-pyrido(4,3-b)indole inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]
CTD
PMID:28629854
NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588
G
Slc47a1
solute carrier family 47 member 1
decreases activity
ISO
3-amino-1-methyl-5H-pyrido(4,3-b)indole results in decreased activity of SLC47A1 protein
CTD
PMID:30189235
NCBI chr10:46,533,580...46,590,128
Ensembl chr10:46,533,583...46,587,096
G
Slc47a2
solute carrier family 47 member 2
decreases activity
ISO
3-amino-1-methyl-5H-pyrido(4,3-b)indole results in decreased activity of SLC47A2 protein
CTD
PMID:30189235
NCBI chr10:46,490,262...46,532,954
Ensembl chr10:46,489,831...46,533,425
G
Sult1a1
sulfotransferase family 1A member 1
multiple interactions
ISO
SULT1A1 protein results in increased metabolism of and results in increased susceptibility to 3-amino-1-methyl-5H-pyrido(4,3-b)indole
CTD
PMID:28160022
NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131
G
Th
tyrosine hydroxylase
decreases activity
EXP
3-amino-1-methyl-5H-pyrido(4,3-b)indole results in decreased activity of TH protein
CTD
PMID:2904812
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227
G
Tph1
tryptophan hydroxylase 1
decreases activity
ISO
3-amino-1-methyl-5H-pyrido(4,3-b)indole results in decreased activity of TPH1 protein
CTD
PMID:1989631
NCBI chr 1:106,293,695...106,314,628
Ensembl chr 1:106,085,953...106,312,484
G
Ahr
aryl hydrocarbon receptor
increases expression
ISO
annomontine results in increased expression of AHR mRNA
CTD
PMID:20449727
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
G
Ahrr
aryl-hydrocarbon receptor repressor
increases expression
ISO
annomontine results in increased expression of AHRR mRNA
CTD
PMID:20449727
NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
annomontine results in increased expression of CYP1A1 mRNA
CTD
PMID:20449727
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Ahr
aryl hydrocarbon receptor
multiple interactions increases activity
ISO
norharman inhibits the reaction [Lipids metabolite results in increased activity of AHR protein] norharman results in increased activity of AHR protein
CTD
PMID:27020609 PMID:28336214
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
G
Casp3
caspase 3
increases cleavage increases expression
ISO
norharman results in increased cleavage of CASP3 protein norharman results in increased expression of CASP3 mRNA
CTD
PMID:35985368
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Casp7
caspase 7
increases expression
ISO
norharman results in increased expression of CASP7 mRNA
CTD
PMID:35985368
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
G
Casp9
caspase 9
increases expression
ISO
norharman results in increased expression of CASP9 mRNA
CTD
PMID:35985368
Ensembl chr 5:159,391,188...159,409,648
G
Cat
catalase
decreases activity
ISO
norharman results in decreased activity of CAT protein
CTD
PMID:35985368
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression
ISO
CYP1A1 protein affects the metabolism of [norharman co-treated with aniline] norharman results in increased expression of CYP1A1 mRNA; norharman results in increased expression of CYP1A1 protein
CTD
PMID:15279827 PMID:28336214
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
ISO
CYP1A2 protein affects the metabolism of [norharman co-treated with aniline]
CTD
PMID:15279827
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions
ISO
CYP1B1 protein affects the metabolism of [norharman co-treated with aniline]
CTD
PMID:15279827
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions
ISO
CYP2B6 protein affects the metabolism of [norharman co-treated with aniline]
CTD
PMID:15279827
NCBI chr 1:90,780,468...90,859,852
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
multiple interactions
ISO
CYP2D6 protein affects the metabolism of [norharman co-treated with aniline]
CTD
PMID:15279827
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
ISO
CYP2E1 protein affects the metabolism of [norharman co-treated with aniline]
CTD
PMID:15279827
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
CYP3A4 protein affects the metabolism of [norharman co-treated with aniline]
CTD
PMID:15279827
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
G
Maoa
monoamine oxidase A
decreases activity
ISO
norharman results in decreased activity of MAOA protein
CTD
PMID:28057462
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
G
Maob
monoamine oxidase B
multiple interactions decreases activity
ISO
norharman inhibits the reaction [MAOB protein results in increased oxidation of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] norharman results in decreased activity of MAOB protein
CTD
PMID:21554916
NCBI chr X:8,490,405...8,594,065
Ensembl chr X:8,490,344...8,594,375
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression
ISO
norharman results in increased expression of NFE2L2 protein
CTD
PMID:35985368
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
norharman results in increased expression of NQO1 mRNA
CTD
PMID:35985368
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
norharman results in increased cleavage of PARP1 protein
CTD
PMID:35985368
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
G
Slc22a1
solute carrier family 22 member 1
decreases activity multiple interactions
ISO
norharman results in decreased activity of SLC22A1 protein norharman inhibits the reaction [SLC22A1 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]
CTD
PMID:30189235
NCBI chr 1:50,624,339...50,651,437
Ensembl chr 1:50,624,377...50,651,436
G
Slc22a2
solute carrier family 22 member 2
decreases activity multiple interactions
ISO
norharman results in decreased activity of SLC22A2 protein norharman inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]
CTD
PMID:30189235
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
G
Slc22a3
solute carrier family 22 member 3
decreases activity multiple interactions
ISO
norharman results in decreased activity of SLC22A3 protein norharman inhibits the reaction [SLC22A3 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]
CTD
PMID:30189235
NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:50,783,218...50,872,353
G
Tp53
tumor protein p53
affects activity
ISO
norharman metabolite affects the activity of TP53 protein
CTD
PMID:35435491
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
G
Aarsd1
alanyl-tRNA synthetase domain containing 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of AARSD1 protein]
CTD
PMID:35362542
NCBI chr10:86,840,874...86,854,077
Ensembl chr10:86,840,874...86,849,734
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions
ISO
evodiamine inhibits the reaction [TNF protein results in increased expression of ABCB1 protein]
CTD
PMID:15710601
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
G
Abcg1
ATP binding cassette subfamily G member 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dietary Fats results in decreased expression of ABCG1 mRNA]; evodiamine inhibits the reaction [Dietary Fats results in decreased expression of ABCG1 protein]
CTD
PMID:34902249
NCBI chr20:9,128,056...9,184,312
Ensembl chr20:9,127,803...9,186,563
G
Abcg8
ATP binding cassette subfamily G member 8
multiple interactions
ISO
evodiamine inhibits the reaction [Dietary Fats results in increased expression of ABCG8 protein]
CTD
PMID:34902249
NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:15,698,448...15,717,730
G
Abraxas2
abraxas 2, BRISC complex subunit
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ABRAXAS2 protein]
CTD
PMID:35362542
NCBI chr 1:197,077,177...197,102,753
Ensembl chr 1:197,077,158...197,102,757
G
Acap2
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ACAP2 protein]
CTD
PMID:35362542
NCBI chr11:83,043,442...83,159,105
Ensembl chr11:83,043,511...83,159,107
G
Acp6
acid phosphatase 6, lysophosphatidic
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ACP6 protein]
CTD
PMID:35362542
NCBI chr 2:187,400,786...187,421,877
Ensembl chr 2:187,349,186...187,422,743
G
Acsm3
acyl-CoA synthetase medium-chain family member 3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ACSM3 protein]
CTD
PMID:35362542
NCBI chr 1:183,564,652...183,591,328
Ensembl chr 1:183,564,635...183,591,437
G
Acss2
acyl-CoA synthetase short-chain family member 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ACSS2 protein]
CTD
PMID:35362542
NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
EXP ISO
evodiamine inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]
CTD
PMID:28303407
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
G
Actb
actin, beta
decreases expression
ISO
evodiamine results in decreased expression of ACTB mRNA
CTD
PMID:32057900
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242
G
Actg1
actin, gamma 1
increases expression
ISO
evodiamine results in increased expression of ACTG1 mRNA
CTD
PMID:32057900
NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951
G
Adam10
ADAM metallopeptidase domain 10
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ADAM10 protein]
CTD
PMID:35362542
NCBI chr 8:80,226,862...80,358,728
Ensembl chr 8:80,226,674...80,361,600
G
Aip
aryl-hydrocarbon receptor-interacting protein
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of AIP protein]
CTD
PMID:35362542
NCBI chr 1:210,837,473...210,848,691
Ensembl chr 1:210,836,755...210,848,634
G
Akap12
A-kinase anchoring protein 12
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of AKAP12 protein]
CTD
PMID:35362542
NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557
G
Akap8
A-kinase anchoring protein 8
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of AKAP8 protein]
CTD
PMID:35362542
NCBI chr 7:11,966,769...11,983,056
Ensembl chr 7:11,966,772...11,982,900
G
Akt1
AKT serine/threonine kinase 1
multiple interactions decreases expression decreases phosphorylation
ISO EXP
evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of AKT1 protein]; evodiamine inhibits the reaction [TNF protein results in increased activity of AKT1 protein]; evodiamine results in decreased expression of and results in decreased phosphorylation of AKT1 protein; Wortmannin promotes the reaction [evodiamine results in decreased phosphorylation of AKT1 protein] evodiamine results in decreased expression of AKT1 mRNA evodiamine inhibits the reaction [INS1 results in increased phosphorylation of AKT1 protein]; evodiamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of AKT1 protein]
CTD
PMID:15710601 PMID:17884939 PMID:20005289 PMID:28303407 PMID:34401976 PMID:34824590 PMID:35899176 PMID:38878560 More...
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
G
Aldoc
aldolase, fructose-bisphosphate C
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ALDOC protein]
CTD
PMID:35362542
NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,715,489...63,719,133
G
Amot
angiomotin
decreases expression
ISO
evodiamine results in decreased expression of AMOT mRNA
CTD
PMID:32057900
NCBI chr X:113,778,990...113,837,846
Ensembl chr X:113,781,526...113,837,482
G
Ampd3
adenosine monophosphate deaminase 3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of AMPD3 protein]
CTD
PMID:35362542
NCBI chr 1:174,319,526...174,364,605
Ensembl chr 1:174,294,867...174,364,608
G
Ano10
anoctamin 10
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ANO10 protein]
CTD
PMID:35362542
NCBI chr 8:130,719,177...130,838,243
Ensembl chr 8:130,718,755...130,877,636
G
Ap3m1
adaptor related protein complex 3 subunit mu 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of AP3M1 protein]
CTD
PMID:35362542
NCBI chr15:3,285,591...3,314,139
Ensembl chr15:3,295,444...3,313,104
G
Apc
APC regulator of WNT signaling pathway
affects response to substance multiple interactions
ISO
APC protein mutant form affects the susceptibility to evodiamine [APC protein mutant form affects the susceptibility to evodiamine] which affects the expression of IL15 protein; [APC protein mutant form affects the susceptibility to evodiamine] which affects the expression of IL17A protein; [APC protein mutant form affects the susceptibility to evodiamine] which affects the expression of IL1B protein; [APC protein mutant form affects the susceptibility to evodiamine] which affects the expression of IL2 protein; [APC protein mutant form affects the susceptibility to evodiamine] which affects the expression of IL22 protein; [APC protein mutant form affects the susceptibility to evodiamine] which affects the expression of IL6 protein; [APC protein mutant form affects the susceptibility to evodiamine] which affects the expression of S100A9 protein; [APC protein mutant form affects the susceptibility to evodiamine] which affects the expression of TNF protein; [APC protein mutant form affects the susceptibility to evodiamine] which affects the phosphorylation of NFKBIA protein; [APC protein mutant form affects the susceptibility to evodiamine] which affects the phosphorylation of RELA protein
CTD
PMID:35362542
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022
G
Apoe
apolipoprotein E
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of APOE protein]
CTD
PMID:35362542
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
G
Appl2
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of APPL2 protein]
CTD
PMID:35362542
NCBI chr 7:22,019,480...22,072,386
Ensembl chr 7:22,022,963...22,072,385
G
Ar
androgen receptor
multiple interactions
ISO
evodiamine inhibits the reaction [Dihydrotestosterone promotes the reaction [SRC protein binds to AR protein]]
CTD
PMID:34713388
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
G
Arfgap2
ARF GTPase activating protein 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ARFGAP2 protein]
CTD
PMID:35362542
NCBI chr 3:97,692,105...97,704,246
Ensembl chr 3:97,692,110...97,704,247
G
Arl3
ARF like GTPase 3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ARL3 protein]
CTD
PMID:35362542
NCBI chr 1:255,342,078...255,388,087
Ensembl chr 1:255,342,076...255,388,279
G
Arpc5
actin related protein 2/3 complex, subunit 5
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ARPC5 protein]
CTD
PMID:35362542
NCBI chr13:67,454,379...67,463,288
Ensembl chr13:67,437,027...67,463,283
G
Atp5mf
ATP synthase membrane subunit f
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ATP5MF protein]
CTD
PMID:35362542
NCBI chr12:14,535,435...14,542,007
Ensembl chr12:14,522,832...14,542,709
G
Atp6v0c
ATPase H+ transporting V0 subunit C
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ATP6V0C protein]
CTD
PMID:35362542
NCBI chr10:13,700,764...13,707,147
Ensembl chr10:13,700,764...13,706,245
G
Atp6v0d1
ATPase H+ transporting V0 subunit D1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ATP6V0D1 protein]
CTD
PMID:35362542
NCBI chr19:50,313,268...50,357,248
Ensembl chr19:50,313,273...50,357,395
G
Atp6v1f
ATPase H+ transporting V1 subunit F
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ATP6V1F protein]
CTD
PMID:35362542
NCBI chr 4:59,033,020...59,035,980
G
Axl
Axl receptor tyrosine kinase
increases expression
ISO
evodiamine results in increased expression of AXL mRNA
CTD
PMID:32057900
NCBI chr 1:90,392,864...90,424,123
Ensembl chr 1:90,392,864...90,424,009
G
B3gnt7
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of B3GNT7 protein]
CTD
PMID:35362542
NCBI chr 9:94,404,197...94,408,148
Ensembl chr 9:94,404,135...94,408,147
G
Bad
BCL2-associated agonist of cell death
increases expression
ISO
evodiamine results in increased expression of BAD protein
CTD
PMID:32425601
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
G
Banf1
barrier to autointegration nuclear assembly factor 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of BANF1 protein]
CTD
PMID:35362542
NCBI chr 1:212,101,523...212,103,568
Ensembl chr 1:212,101,523...212,103,552
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [evodiamine results in increased expression of BAX protein]; 3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide inhibits the reaction [evodiamine results in increased expression of BAX protein]; XMU-MP-1 inhibits the reaction [evodiamine results in increased expression of BAX protein] evodiamine results in increased expression of BAX mRNA; evodiamine results in increased expression of BAX protein
CTD
PMID:32057900 PMID:32425601 PMID:34824590 PMID:35899176 PMID:38878560
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression increases cleavage
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [evodiamine results in increased cleavage of BCL2 protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of BCL2 protein]; XMU-MP-1 inhibits the reaction [evodiamine results in decreased expression of BCL2 protein] evodiamine results in decreased expression of BCL2 mRNA; evodiamine results in decreased expression of BCL2 protein
CTD
PMID:15710601 PMID:20005289 PMID:32057900 PMID:32183146 PMID:32425601 PMID:34824590 PMID:35899176 PMID:38878560 More...
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
G
Bcl2a1
BCL2-related protein A1
multiple interactions
ISO
evodiamine inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein]
CTD
PMID:15710601
NCBI chr 8:98,596,806...98,604,890
Ensembl chr 8:98,596,650...98,604,890
G
Bcl2l1
Bcl2-like 1
multiple interactions decreases expression
ISO
evodiamine inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein]; HGF protein affects the reaction [evodiamine results in decreased expression of BCL2L1 protein]
CTD
PMID:15710601 PMID:32183146
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
G
Bdnf
brain-derived neurotrophic factor
increases expression
ISO
evodiamine results in increased expression of BDNF mRNA
CTD
PMID:38878560
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
G
Becn1
beclin 1
increases expression
ISO
evodiamine results in increased expression of BECN1 mRNA; evodiamine results in increased expression of BECN1 protein
CTD
PMID:34824590
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
G
Birc2
baculoviral IAP repeat-containing 2
multiple interactions
ISO
evodiamine inhibits the reaction [TNF protein results in increased expression of BIRC2 protein]
CTD
PMID:15710601
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911
G
Birc3
baculoviral IAP repeat-containing 3
multiple interactions
ISO
evodiamine inhibits the reaction [TNF protein results in increased expression of BIRC3 protein]
CTD
PMID:15710601
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590
G
Birc5
baculoviral IAP repeat-containing 5
multiple interactions decreases expression
ISO
evodiamine inhibits the reaction [TNF protein results in increased expression of BIRC5 protein]; HGF protein affects the reaction [evodiamine results in decreased expression of BIRC5 protein]; XMU-MP-1 inhibits the reaction [evodiamine results in decreased expression of BIRC5 protein] evodiamine results in decreased expression of BIRC5 mRNA; evodiamine results in decreased expression of BIRC5 protein
CTD
PMID:15710601 PMID:32057900 PMID:32183146
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
G
Bpnt2
3'(2'), 5'-bisphosphate nucleotidase 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of BPNT2 protein]
CTD
PMID:35362542
NCBI chr 5:22,573,241...22,600,126
Ensembl chr 5:22,570,165...22,600,126
G
Brk1
BRICK1 subunit of SCAR/WAVE actin nucleating complex
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of BRK1 protein]
CTD
PMID:35362542
NCBI chr 4:148,306,436...148,321,668
Ensembl chr 4:148,306,398...148,321,984
G
C3
complement C3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of C3 protein]
CTD
PMID:35362542
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
G
Ca1
carbonic anhydrase 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of CAR1 protein]
CTD
PMID:35362542
NCBI chr 2:88,550,681...88,593,454
Ensembl chr 2:88,495,475...88,593,454
G
Calca
calcitonin-related polypeptide alpha
multiple interactions
ISO
evodiamine inhibits the reaction [Imiquimod results in increased expression of CALCA mRNA]; evodiamine inhibits the reaction [Imiquimod results in increased expression of CALCA protein]
CTD
PMID:38948922
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
G
Cask
calcium/calmodulin dependent serine protein kinase
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of CASK protein]
CTD
PMID:35362542
NCBI chr X:11,572,328...11,915,831
Ensembl chr X:11,572,636...11,911,948
G
Casp1
caspase 1
multiple interactions
EXP
evodiamine inhibits the reaction [Uric Acid results in increased expression of and results in increased cleavage of CASP1 protein]
CTD
PMID:37555854
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
G
Casp3
caspase 3
multiple interactions increases expression increases cleavage
ISO
[HGF protein co-treated with evodiamine] results in increased cleavage of CASP3 protein; [tetramethylpyrazine co-treated with evodiamine] results in increased activity of CASP3 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [evodiamine results in increased activity of and results in increased cleavage of CASP3 protein]; EUK-134 inhibits the reaction [evodiamine results in increased cleavage of CASP3 protein]; evodiamine results in increased activity of and results in increased cleavage of CASP3 protein; evodiamine results in increased expression of and results in increased cleavage of CASP3 protein; Rotenone inhibits the reaction [evodiamine results in increased cleavage of CASP3 protein] evodiamine results in increased expression of CASP3 mRNA; evodiamine results in increased expression of CASP3 protein
CTD
PMID:20005289 PMID:32057900 PMID:32183146 PMID:32425601 PMID:34808100 PMID:34824590 PMID:35899176 PMID:39486648 More...
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Casp8
caspase 8
increases expression
ISO
evodiamine results in increased expression of CASP8 mRNA; evodiamine results in increased expression of CASP8 protein
CTD
PMID:34824590
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
G
Casp9
caspase 9
increases cleavage
ISO
evodiamine results in increased cleavage of CASP9 protein
CTD
PMID:35899176
Ensembl chr 5:159,391,188...159,409,648
G
Ccn2
cellular communication network factor 2
multiple interactions decreases expression
EXP ISO
evodiamine inhibits the reaction [TGFB1 protein results in increased expression of CCN2 protein] evodiamine results in decreased expression of CCN2 protein XMU-MP-1 inhibits the reaction [evodiamine results in decreased expression of CCN2 protein]
CTD
PMID:28303407 PMID:32057900
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976
G
Ccnb1
cyclin B1
increases expression
ISO
evodiamine results in increased expression of CCNB1 protein
CTD
PMID:35899176
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
G
Ccnd1
cyclin D1
multiple interactions decreases expression increases expression
ISO
evodiamine inhibits the reaction [TNF protein results in increased expression of CCND1 protein] evodiamine results in decreased expression of CCND1 protein evodiamine results in increased expression of CCND1 mRNA
CTD
PMID:15710601 PMID:32183146 PMID:32425601 PMID:38878560
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
G
Ccne2
cyclin E2
decreases expression
ISO
evodiamine results in decreased expression of CCNE2 mRNA
CTD
PMID:32057900
NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:29,082,703...29,094,882
G
Cd274
CD274 molecule
decreases expression multiple interactions
ISO
evodiamine results in decreased expression of CD274 mRNA; evodiamine results in decreased expression of CD274 protein evodiamine inhibits the reaction [IFNG protein results in increased expression of CD274 mRNA]; evodiamine inhibits the reaction [Lactic Acid results in increased expression of CD274 mRNA]; evodiamine inhibits the reaction [Lactic Acid results in increased expression of CD274 protein]
CTD
PMID:33208183 PMID:37611839
NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:236,496,463...236,549,951
G
Cd34
CD34 molecule
multiple interactions
ISO
evodiamine inhibits the reaction [TGFB1 protein results in decreased expression of CD34 protein]
CTD
PMID:28303407
NCBI chr13:109,008,786...109,029,317
Ensembl chr13:109,008,623...109,029,315
G
Cd68
Cd68 molecule
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of CD68 protein]
CTD
PMID:35362542
NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540
G
Cd74
CD74 molecule
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of CD74 protein]
CTD
PMID:35362542
NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410
G
Cdc25c
cell division cycle 25C
decreases phosphorylation
ISO
evodiamine results in decreased phosphorylation of CDC25C protein
CTD
PMID:35899176
NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292
G
Cdh1
cadherin 1
increases expression
ISO
evodiamine results in increased expression of CDH1 protein
CTD
PMID:32425601
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
G
Cdh2
cadherin 2
decreases expression
ISO
evodiamine results in decreased expression of CDH2 protein
CTD
PMID:32425601
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
G
Cdk1
cyclin-dependent kinase 1
increases phosphorylation
ISO
evodiamine results in increased phosphorylation of CDK1 protein
CTD
PMID:35899176
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
G
Cds2
CDP-diacylglycerol synthase 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of CDS2 protein]
CTD
PMID:35362542
NCBI chr 3:139,967,870...140,006,459
Ensembl chr 3:139,967,742...140,009,201
G
Cflar
CASP8 and FADD-like apoptosis regulator
multiple interactions
ISO
evodiamine inhibits the reaction [TNF protein results in increased expression of CFLAR protein]
CTD
PMID:15710601
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434
G
Chga
chromogranin A
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of CHGA protein]
CTD
PMID:35362542
NCBI chr 6:127,460,895...127,472,238
Ensembl chr 6:127,460,854...127,472,237
G
Chordc1
cysteine and histidine rich domain containing 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of CHORDC1 protein]
CTD
PMID:35362542
NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:23,650,865...23,677,696
G
Chp1
calcineurin-like EF-hand protein 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of CHP1 protein]
CTD
PMID:35362542
NCBI chr 3:126,989,800...127,025,071
Ensembl chr 3:126,989,579...127,042,443
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
multiple interactions
ISO
evodiamine inhibits the reaction [TNF protein results in increased activity of CHUK protein]
CTD
PMID:15710601
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:252,908,749...252,944,273
G
Cisd1
CDGSH iron sulfur domain 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of CISD1 protein]
CTD
PMID:35362542
NCBI chr20:17,254,462...17,267,843
Ensembl chr20:17,254,187...17,271,042
G
Clpp
caseinolytic mitochondrial matrix peptidase proteolytic subunit
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of CLPP protein]
CTD
PMID:35362542
NCBI chr 9:1,917,305...1,924,706
Ensembl chr 9:1,918,682...1,924,705
G
Col1a2
collagen type I alpha 2 chain
multiple interactions
EXP
evodiamine inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 protein]
CTD
PMID:28303407
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995
G
Col3a1
collagen type III alpha 1 chain
multiple interactions
EXP
evodiamine inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 protein]
CTD
PMID:28303407
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
G
Col4a4
collagen type IV alpha 4 chain
decreases expression
ISO
evodiamine results in decreased expression of COL4A4 mRNA
CTD
PMID:38878560
NCBI chr 9:91,281,324...91,323,577
Ensembl chr 9:91,203,670...91,323,577
G
Col6a1
collagen type VI alpha 1 chain
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of COL6A1 protein]
CTD
PMID:35362542
NCBI chr20:11,905,690...11,924,111
Ensembl chr20:11,905,457...11,924,107
G
Col6a2
collagen type VI alpha 2 chain
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of COL6A2 protein]
CTD
PMID:35362542
NCBI chr20:12,021,182...12,048,932
Ensembl chr20:12,021,265...12,057,042
G
Col6a3
collagen type VI alpha 3 chain
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of COL6A3 protein]
CTD
PMID:35362542
NCBI chr 9:98,809,171...98,887,060
Ensembl chr 9:98,809,171...98,886,990
G
Colgalt1
collagen beta(1-O)galactosyltransferase 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of COLGALT1 protein]
CTD
PMID:35362542
NCBI chr16:18,353,779...18,366,087
Ensembl chr16:18,353,570...18,366,086
G
Copz1
COPI coat complex subunit zeta 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of COPZ1 protein]
CTD
PMID:35362542
NCBI chr 7:136,287,696...136,314,131
Ensembl chr 7:136,288,032...136,314,135
G
Coq6
coenzyme Q6 monooxygenase
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of COQ6 protein]
CTD
PMID:35362542
NCBI chr 6:109,738,934...109,750,315
Ensembl chr 6:109,738,951...109,750,310
G
Cox17
cytochrome c oxidase copper chaperone COX17
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of COX17 protein]
CTD
PMID:35362542
NCBI chr11:75,906,245...75,912,036
Ensembl chr11:75,906,248...75,912,019
G
Cox7a2
cytochrome c oxidase subunit 7A2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of COX7A2 protein]
CTD
PMID:35362542
NCBI chr 8:89,597,051...89,611,032
Ensembl chr14:55,514,261...55,514,512 Ensembl chr 8:55,514,261...55,514,512
G
Cpne1
copine 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of CPNE1 protein]
CTD
PMID:35362542
NCBI chr 3:165,047,615...165,089,994
G
Csnk1a1
casein kinase 1, alpha 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of CSNK1A1 protein]
CTD
PMID:35362542
NCBI chr18:57,285,156...57,320,540
Ensembl chr18:57,287,412...57,320,538
G
Csnk1d
casein kinase 1, delta
increases expression
ISO
evodiamine results in increased expression of CSNK1D mRNA
CTD
PMID:32057900
NCBI chr10:106,713,497...106,754,953
Ensembl chr10:106,694,279...106,754,953
G
Cth
cystathionine gamma-lyase
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of CTH protein]
CTD
PMID:35362542
NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066
G
Ctnnb1
catenin beta 1
decreases expression
ISO
evodiamine results in decreased expression of CTNNB1 protein
CTD
PMID:32425601
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
G
Ctsc
cathepsin C
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of CTSC protein]
CTD
PMID:35362542
NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:151,441,032...151,474,082
G
Cygb
cytoglobin
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of CYGB protein]
CTD
PMID:35362542
NCBI chr10:102,376,506...102,386,272
Ensembl chr10:102,376,507...102,386,272
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
ISO
evodiamine analog results in increased expression of CYP1B1 mRNA; evodiamine results in increased expression of CYP1B1 mRNA
CTD
PMID:34955744
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
G
Dapk3
death-associated protein kinase 3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of DAPK3 protein]
CTD
PMID:35362542
NCBI chr 7:9,174,903...9,183,272
Ensembl chr 7:9,174,904...9,183,272
G
Dctn3
dynactin subunit 3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of DCTN3 protein]
CTD
PMID:35362542
NCBI chr 5:61,676,950...61,684,958
Ensembl chr 5:61,676,950...61,684,903
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
ISO
EUK-134 inhibits the reaction [evodiamine results in increased expression of DDIT3 protein]
CTD
PMID:34808100
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
G
Ddx23
DEAD-box helicase 23
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of DDX23 protein]
CTD
PMID:35362542
NCBI chr 7:131,676,636...131,693,917
Ensembl chr 7:131,676,636...131,689,074
G
Dhdh
dihydrodiol dehydrogenase
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of DHDH protein]
CTD
PMID:35362542
NCBI chr 1:105,088,108...105,102,560
Ensembl chr 1:105,090,309...105,101,567
G
Dhodh
dihydroorotate dehydrogenase
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of DHODH protein]
CTD
PMID:35362542
NCBI chr19:54,460,636...54,483,049
Ensembl chr19:54,468,690...54,514,496
G
Diaph1
diaphanous-related formin 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of DIAPH1 protein]
CTD
PMID:35362542
NCBI chr18:29,920,889...30,020,280
Ensembl chr18:29,920,889...30,020,280
G
Diaph2
diaphanous-related formin 2
decreases expression
ISO
evodiamine results in decreased expression of DIAPH2 mRNA
CTD
PMID:32057900
NCBI chr X:96,700,535...97,528,080
Ensembl chr X:96,700,726...97,528,080
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of DNAJB4 protein]
CTD
PMID:35362542
NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042
G
Dnm1l
dynamin 1-like
multiple interactions increases phosphorylation
ISO
Rotenone inhibits the reaction [evodiamine results in increased phosphorylation of DNM1L protein]
CTD
PMID:34808100
NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420
G
Dock1
dedicator of cyto-kinesis 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of DOCK1 protein]
CTD
PMID:35362542
NCBI chr 1:198,897,021...199,413,636
Ensembl chr 1:198,897,045...199,413,627
G
Ecpas
Ecm29 proteasome adaptor and scaffold
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ECPAS protein]
CTD
PMID:35362542
NCBI chr 5:78,398,449...78,509,077
Ensembl chr 5:78,398,718...78,512,908
G
Efna1
ephrin A1
decreases expression
ISO
evodiamine results in decreased expression of EFNA1 mRNA
CTD
PMID:38878560
NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726
G
Egf
epidermal growth factor
multiple interactions decreases expression
ISO
evodiamine inhibits the reaction [EGF protein results in increased expression of XIAP protein] evodiamine results in decreased expression of EGF mRNA; evodiamine results in decreased expression of EGF protein
CTD
PMID:34824590 PMID:39334374
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297
G
Egfr
epidermal growth factor receptor
multiple interactions decreases expression increases phosphorylation
ISO
EGFR mutant form inhibits the reaction [evodiamine results in increased phosphorylation of MAPK1 protein]; EGFR mutant form inhibits the reaction [evodiamine results in increased phosphorylation of MAPK3 protein]; EGFR mutant form inhibits the reaction [evodiamine results in increased phosphorylation of PLCG1 protein]; EGFR mutant form inhibits the reaction [evodiamine results in increased phosphorylation of PRKCA protein]; RTKI cpd inhibits the reaction [evodiamine results in increased phosphorylation of EGFR protein] evodiamine results in decreased expression of EGFR mRNA; evodiamine results in decreased expression of EGFR protein
CTD
PMID:19854188 PMID:34824590
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
decreases expression multiple interactions
ISO
evodiamine results in decreased expression of EIF2AK3 protein EUK-134 inhibits the reaction [evodiamine results in decreased expression of EIF2AK3 protein]
CTD
PMID:34808100
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
G
Eif2b5
eukaryotic translation initiation factor 2B subunit epsilon
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of EIF2B5 protein]
CTD
PMID:35362542
NCBI chr11:93,898,814...93,909,431
Ensembl chr11:93,898,814...93,908,800
G
Eif4b
eukaryotic translation initiation factor 4B
decreases expression
ISO
evodiamine results in decreased expression of EIF4B mRNA
CTD
PMID:38878560
NCBI chr 7:135,085,259...135,107,054
Ensembl chr 7:135,085,066...135,107,064
G
Eno2
enolase 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ENO2 protein]
CTD
PMID:35362542
NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:159,258,371...159,267,220
G
Epha2
Eph receptor A2
increases expression
ISO
evodiamine results in increased expression of EPHA2 mRNA
CTD
PMID:38878560
NCBI chr 5:158,888,629...158,917,100
Ensembl chr 5:158,888,629...158,917,234
G
Erbb2
erb-b2 receptor tyrosine kinase 2
decreases expression
ISO
evodiamine results in decreased expression of ERBB2 protein
CTD
PMID:39334374
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481
G
Ermp1
endoplasmic reticulum metallopeptidase 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ERMP1 protein]
CTD
PMID:35362542
NCBI chr 1:236,801,459...236,835,656
Ensembl chr 1:236,801,466...236,839,197
G
Ero1a
endoplasmic reticulum oxidoreductase 1 alpha
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ERO1A protein]
CTD
PMID:35362542
NCBI chr15:20,974,771...21,010,170
Ensembl chr15:20,972,679...21,018,039
G
Esr2
estrogen receptor 2
multiple interactions
ISO
[evodiamine co-treated with tetramethylpyrazine] results in decreased expression of ESR2 mRNA; [evodiamine co-treated with tetramethylpyrazine] results in decreased expression of ESR2 protein; [evodiamine co-treated with tetramethylpyrazine] results in increased methylation of ESR2 promoter; [tetramethylpyrazine co-treated with evodiamine] inhibits the reaction [POU5F1 protein binds to ESR2 promoter]
CTD
PMID:39486648
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
G
F11r
F11 receptor
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of F11R protein]
CTD
PMID:35362542
NCBI chr13:86,406,229...86,429,819
Ensembl chr13:86,406,218...86,429,816
G
Fabp5
fatty acid binding protein 5
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of FABP5 protein]
CTD
PMID:35362542
NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:93,672,458...93,676,127
G
Fam136a
family with sequence similarity 136, member A
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of FAM136A protein]
CTD
PMID:35362542
NCBI chr 4:120,362,563...120,368,479
Ensembl chr 4:120,362,561...120,368,479
G
Fam234a
family with sequence similarity 234, member A
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of FAM234A protein]
CTD
PMID:35362542
NCBI chr10:15,736,741...15,768,043
Ensembl chr10:15,736,742...15,749,835
G
Faslg
Fas ligand
multiple interactions increases expression
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [evodiamine results in increased expression of FASLG protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [evodiamine results in increased expression of FASLG protein]; wortmannin inhibits the reaction [evodiamine results in increased expression of FASLG protein]
CTD
PMID:20005289
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
G
Fat1
FAT atypical cadherin 1
increases expression
ISO
evodiamine results in increased expression of FAT1 mRNA
CTD
PMID:32057900
NCBI chr16:53,909,759...54,029,175
Ensembl chr16:53,909,556...54,028,609
G
Fblim1
filamin binding LIM protein 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of FBLIM1 protein]
CTD
PMID:35362542
NCBI chr 5:159,167,004...159,198,578
Ensembl chr 5:159,167,004...159,196,853
G
Fbn1
fibrillin 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of FBN1 protein]
CTD
PMID:35362542
NCBI chr 3:133,007,693...133,204,277
Ensembl chr 3:133,008,361...133,204,283
G
Fdx1
ferredoxin 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of FDX1 protein]
CTD
PMID:35362542
NCBI chr 8:61,164,839...61,183,645
Ensembl chr 8:61,164,839...61,183,583
G
Fga
fibrinogen alpha chain
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of FGA protein]
CTD
PMID:35362542
NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:170,672,012...170,679,577
G
Fgf1
fibroblast growth factor 1
increases expression
ISO
evodiamine results in increased expression of FGF1 mRNA
CTD
PMID:32057900
NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393
G
Fgfr2
fibroblast growth factor receptor 2
decreases expression
ISO
evodiamine results in decreased expression of FGFR2 mRNA
CTD
PMID:38878560
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914
G
Fgfr3
fibroblast growth factor receptor 3
increases expression
ISO
evodiamine results in increased expression of FGFR3 mRNA
CTD
PMID:31835579
NCBI chr14:81,211,800...81,227,215
Ensembl chr14:81,211,800...81,227,209
G
Fjx1
four-jointed box kinase 1
decreases expression
ISO
evodiamine results in decreased expression of FJX1 mRNA
CTD
PMID:32057900
NCBI chr 3:109,229,223...109,231,324
Ensembl chr 3:109,227,170...109,232,479
G
Fn1
fibronectin 1
multiple interactions
EXP
evodiamine inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein]
CTD
PMID:28303407
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
evodiamine inhibits the reaction [Nitroglycerin results in increased expression of FOS mRNA]
CTD
PMID:32147481
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
G
Fuca1
alpha-L-fucosidase 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of FUCA1 protein]
CTD
PMID:35362542
NCBI chr 5:153,436,262...153,453,512
Ensembl chr 5:153,436,248...153,453,511
G
Fzd9
frizzled class receptor 9
increases expression
ISO
evodiamine results in increased expression of FZD9 mRNA
CTD
PMID:31835579
NCBI chr12:27,063,640...27,065,954
Ensembl chr12:27,063,415...27,074,485
G
Galk1
galactokinase 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GALK1 protein]
CTD
PMID:35362542
NCBI chr10:101,742,067...101,746,244
Ensembl chr10:101,735,061...101,746,258
G
Galnt1
polypeptide N-acetylgalactosaminyltransferase 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GALNT1 protein]
CTD
PMID:35362542
NCBI chr18:15,763,697...15,843,598
Ensembl chr18:15,764,277...15,843,588
G
Galnt3
polypeptide N-acetylgalactosaminyltransferase 3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of GALNT3 protein]
CTD
PMID:35362542
NCBI chr 3:71,150,559...71,187,321
Ensembl chr 3:71,150,571...71,174,323
G
Gbp4
guanylate binding protein 4
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of GBP4 protein]
CTD
PMID:35362542
NCBI chr 2:233,978,163...233,992,124
Ensembl chr 2:233,978,486...233,992,120
G
Gbp7
guanylate binding protein 7
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of GBP7 protein]
CTD
PMID:35362542
NCBI chr 2:233,948,774...233,970,532
Ensembl chr 2:233,948,677...233,970,526
G
Gda
guanine deaminase
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of GDA protein]
CTD
PMID:35362542
NCBI chr 1:228,333,401...228,408,901
Ensembl chr 1:228,333,364...228,409,348
G
Gdpd1
glycerophosphodiester phosphodiesterase domain containing 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GDPD1 protein]
CTD
PMID:35362542
NCBI chr10:72,318,716...72,381,143
Ensembl chr10:72,337,778...72,381,120
G
Ggh
gamma-glutamyl hydrolase
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GGH protein]
CTD
PMID:35362542
NCBI chr 5:38,326,747...38,349,655
Ensembl chr 5:38,326,594...38,349,647
G
Gipc2
GIPC PDZ domain containing family, member 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GIPC2 protein]
CTD
PMID:35362542
NCBI chr 2:243,690,742...243,770,199
Ensembl chr 2:243,690,748...243,770,199
G
Gli1
GLI family zinc finger 1
increases expression
ISO
evodiamine results in increased expression of GLI1 mRNA
CTD
PMID:31835579
NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540
G
Glrx5
glutaredoxin 5
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GLRX5 protein]
CTD
PMID:35362542
NCBI chr 6:129,752,902...129,763,278
Ensembl chr 6:129,752,840...129,763,278
G
Gmpr
guanosine monophosphate reductase
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GMPR protein]
CTD
PMID:35362542
NCBI chr17:19,357,992...19,395,807
Ensembl chr17:19,357,992...19,431,655
G
Gnao1
G protein subunit alpha o1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GNAO1 protein]
CTD
PMID:35362542
NCBI chr19:11,040,788...11,198,437
Ensembl chr19:11,040,788...11,198,437
G
Gng12
G protein subunit gamma 12
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of GNG12 protein]
CTD
PMID:35362542
NCBI chr 4:97,340,830...97,464,422
Ensembl chr 4:97,340,472...97,464,476
G
Golga3
golgin A3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GOLGA3 protein]
CTD
PMID:35362542
NCBI chr12:52,112,129...52,160,311
Ensembl chr12:52,114,590...52,160,226
G
Golga4
golgin A4
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GOLGA4 protein]
CTD
PMID:35362542
NCBI chr 8:127,085,830...127,163,227
Ensembl chr 8:127,085,848...127,163,603
G
Gpc5
glypican 5
increases expression
ISO
evodiamine results in increased expression of GPC5 mRNA
CTD
PMID:32057900
NCBI chr15:98,614,499...100,051,285
Ensembl chr15:98,646,340...100,051,514
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
ISO
evodiamine inhibits the reaction [Carbon Tetrachloride results in increased expression of GPT protein]
CTD
PMID:34218553
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
G
Gpx2
glutathione peroxidase 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GPX2 protein]
CTD
PMID:35362542
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
G
Gpx4
glutathione peroxidase 4
decreases expression multiple interactions
ISO
evodiamine results in decreased expression of GPX4 protein evodiamine inhibits the reaction [Lactic Acid results in increased expression of GPX4 protein]; ferrostatin-1 inhibits the reaction [evodiamine results in decreased expression of GPX4 protein]
CTD
PMID:37611839
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
multiple interactions
EXP
evodiamine inhibits the reaction [Nitroglycerin results in increased expression of and results in increased phosphorylation of GRIA1 protein]
CTD
PMID:32147481
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309
G
Gsk3b
glycogen synthase kinase 3 beta
increases expression
ISO
evodiamine results in increased expression of GSK3B protein
CTD
PMID:32425601
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
G
Gstk1
glutathione S-transferase kappa 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GSTK1 protein]
CTD
PMID:35362542
NCBI chr 4:72,085,532...72,089,934
Ensembl chr 4:72,085,531...72,089,927
G
Gstm5
glutathione S-transferase, mu 5
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GSTM3 protein]
CTD
PMID:35362542
NCBI chr 2:198,219,769...198,222,732
Ensembl chr 2:198,219,647...198,222,731
G
Guk1
guanylate kinase 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GUK1 protein]
CTD
PMID:35362542
NCBI chr10:44,471,075...44,488,332
Ensembl chr10:44,471,085...44,479,355
G
Gyg1
glycogenin 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of GYG1 protein]
CTD
PMID:35362542
NCBI chr 2:104,540,927...104,583,038
Ensembl chr 2:104,540,533...104,582,818
G
H1f1
H1.1 linker histone, cluster member
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of H1F1 protein]
CTD
PMID:35362542
NCBI chr17:41,762,278...41,794,876
G
H2ax
H2A.X variant histone
multiple interactions
ISO
[tetramethylpyrazine co-treated with evodiamine] results in increased expression of H2AX protein
CTD
PMID:39486648
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
G
H6pd
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of H6PD protein]
CTD
PMID:35362542
NCBI chr 5:165,717,456...165,753,158
Ensembl chr 5:165,721,654...165,753,125
G
Hcls1
hematopoietic cell specific Lyn substrate 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of HCLS1 protein]
CTD
PMID:35362542
NCBI chr11:77,322,873...77,346,333
Ensembl chr11:77,322,873...77,346,387
G
Hes1
hes family bHLH transcription factor 1
affects expression
ISO
evodiamine affects the expression of HES1 mRNA
CTD
PMID:31835579
NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061
G
Hes5
hes family bHLH transcription factor 5
increases expression
ISO
evodiamine results in increased expression of HES5 mRNA
CTD
PMID:31835579
NCBI chr 5:170,804,511...170,807,988
Ensembl chr 5:170,803,940...170,806,021
G
Hgf
hepatocyte growth factor
multiple interactions
ISO
[HGF protein co-treated with evodiamine] results in increased cleavage of CASP3 protein; [HGF protein co-treated with evodiamine] results in increased cleavage of PARP1 protein; evodiamine inhibits the reaction [HGF protein results in increased phosphorylation of and affects the localization of STAT3 protein]; evodiamine inhibits the reaction [HGF protein results in increased phosphorylation of MET protein]; evodiamine inhibits the reaction [HGF protein results in increased phosphorylation of SRC protein]; HGF protein affects the reaction [evodiamine results in decreased expression of BCL2L1 protein]; HGF protein affects the reaction [evodiamine results in decreased expression of BIRC5 protein]; HGF protein affects the reaction [evodiamine results in decreased expression of MMP9 protein]; HGF protein affects the reaction [evodiamine results in decreased expression of PTGS2 protein]; MET protein affects the reaction [evodiamine inhibits the reaction [HGF protein results in increased phosphorylation of SRC protein]]; MET protein affects the reaction [evodiamine inhibits the reaction [HGF protein results in increased phosphorylation of STAT3 protein]]
CTD
PMID:32183146
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions decreases expression
ISO
evodiamine inhibits the reaction [Lactic Acid results in increased expression of HIF1A protein] evodiamine results in decreased expression of HIF1A protein
CTD
PMID:37611839
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
G
Hint2
histidine triad nucleotide binding protein 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of HINT2 protein]
CTD
PMID:35362542
NCBI chr 5:62,700,383...62,702,638
Ensembl chr 5:62,700,384...62,702,915
G
Hmgb3
high mobility group box 3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of HMGB3 protein]
CTD
PMID:35362542
NCBI chr X:154,341,106...154,346,087
Ensembl chr X:154,340,935...154,346,097
G
Hnrnpul1
heterogeneous nuclear ribonucleoprotein U-like 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of HNRNPUL1 protein]
CTD
PMID:35362542
NCBI chr 1:90,356,182...90,391,923
Ensembl chr 1:90,356,182...90,390,370
G
Hp
haptoglobin
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of HP protein]
CTD
PMID:35362542
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
increases expression
ISO
evodiamine results in increased expression of HSP90AA1 mRNA
CTD
PMID:38878560
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
increases expression
ISO
evodiamine results in increased expression of HSP90AB1 mRNA
CTD
PMID:38878560
NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
evodiamine inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]
CTD
PMID:15710601
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
G
Ifng
interferon gamma
multiple interactions
ISO
evodiamine inhibits the reaction [IFNG protein results in increased expression of CD274 mRNA]
CTD
PMID:33208183
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
G
Igf2r
insulin-like growth factor 2 receptor
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of IGF2R protein]
CTD
PMID:35362542
NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:50,526,878...50,615,265
G
Igfbp7
insulin-like growth factor binding protein 7
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of IGFBP7 protein]
CTD
PMID:35362542
NCBI chr14:31,091,681...31,151,623
Ensembl chr14:31,091,347...31,151,620
G
Ik
IK cytokine
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of IK protein]
CTD
PMID:35362542
NCBI chr18:28,632,025...28,646,829
Ensembl chr18:28,631,616...28,653,463
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions
ISO
evodiamine inhibits the reaction [TNF protein results in increased activity of IKBKB protein]
CTD
PMID:15710601
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
G
Il15
interleukin 15
multiple interactions
ISO
[APC protein mutant form affects the susceptibility to evodiamine] which affects the expression of IL15 protein
CTD
PMID:35362542
NCBI chr19:42,536,160...42,611,349
Ensembl chr19:42,545,346...42,611,348
G
Il17a
interleukin 17A
multiple interactions
ISO
[APC protein mutant form affects the susceptibility to evodiamine] which affects the expression of IL17A protein; evodiamine inhibits the reaction [Imiquimod results in increased expression of IL17A protein]
CTD
PMID:35362542 PMID:38948922
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
G
Il18
interleukin 18
multiple interactions
EXP
evodiamine inhibits the reaction [Uric Acid results in increased expression of IL18 protein]
CTD
PMID:37555854
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
G
Il1b
interleukin 1 beta
multiple interactions
ISO EXP
[evodiamine co-treated with tetramethylpyrazine] results in decreased expression of IL1B mRNA; evodiamine inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein]; evodiamine inhibits the reaction [IL1B protein results in increased activity of RELA protein] evodiamine inhibits the reaction [Uric Acid results in increased expression of IL1B protein] [APC protein mutant form affects the susceptibility to evodiamine] which affects the expression of IL1B protein; evodiamine inhibits the reaction [Carbon Tetrachloride results in increased expression of IL1B mRNA]; evodiamine inhibits the reaction [Carbon Tetrachloride results in increased expression of IL1B protein]; evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; evodiamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; evodiamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]
CTD
PMID:15710601 PMID:34218553 PMID:34401976 PMID:35362542 PMID:37555854 PMID:39486648 More...
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Il1rn
interleukin 1 receptor antagonist
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of IL1RN protein]
CTD
PMID:35362542
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
G
Il2
interleukin 2
multiple interactions
ISO
[APC protein mutant form affects the susceptibility to evodiamine] which affects the expression of IL2 protein; evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of IL2 protein]
CTD
PMID:35362542
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
G
Il23a
interleukin 23 subunit alpha
multiple interactions
ISO
evodiamine inhibits the reaction [Imiquimod results in increased expression of IL23A protein]
CTD
PMID:38948922
NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:1,306,320...1,308,434
G
Il6
interleukin 6
multiple interactions
ISO
[evodiamine co-treated with tetramethylpyrazine] results in decreased expression of IL6 mRNA; [evodiamine co-treated with tetramethylpyrazine] results in decreased secretion of IL6 protein; evodiamine inhibits the reaction [IL6 protein affects the localization of STAT3 protein]; evodiamine inhibits the reaction [IL6 protein results in increased phosphorylation of RELA protein]; evodiamine inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein] [APC protein mutant form affects the susceptibility to evodiamine] which affects the expression of IL6 protein; evodiamine inhibits the reaction [Carbon Tetrachloride results in increased expression of IL6 mRNA]; evodiamine inhibits the reaction [Carbon Tetrachloride results in increased expression of IL6 protein]; evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]
CTD
PMID:33277208 PMID:34218553 PMID:35362542 PMID:39486648
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
G
Ins1
insulin 1
multiple interactions
ISO
evodiamine inhibits the reaction [INS1 results in increased phosphorylation of AKT1 protein]
CTD
PMID:17884939
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
G
Itih4
inter-alpha-trypsin inhibitor heavy chain 4
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ITIH4 protein]
CTD
PMID:35362542
NCBI chr16:6,086,985...6,102,162
Ensembl chr16:6,086,973...6,102,160
G
Kdm1a
lysine demethylase 1A
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of KDM1A protein]
CTD
PMID:35362542
NCBI chr 5:154,066,436...154,121,913
Ensembl chr 5:154,065,543...154,121,775
G
Klk1c10
kallikrein 1-related peptidase C10
multiple interactions
ISO
evodiamine inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 mRNA]
CTD
PMID:34713388
NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586
G
Lamp2
lysosomal-associated membrane protein 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of LAMP2 protein]
CTD
PMID:35362542
NCBI chr X:122,038,734...122,087,745
Ensembl chr X:121,922,187...122,087,675
G
Lamtor2
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of LAMTOR2 protein]
CTD
PMID:35362542
NCBI chr 2:176,306,353...176,310,617
Ensembl chr 2:176,306,280...176,310,730
G
Lats1
large tumor suppressor kinase 1
increases expression multiple interactions
ISO
evodiamine results in increased expression of LATS1 mRNA evodiamine results in increased expression of and results in increased phosphorylation of LATS1 protein; XMU-MP-1 inhibits the reaction [evodiamine results in increased expression of and results in increased phosphorylation of LATS1 protein]; XMU-MP-1 inhibits the reaction [evodiamine results in increased expression of LATS1 mRNA]
CTD
PMID:32057900
NCBI chr 1:3,980,801...4,014,029
Ensembl chr 1:3,980,544...4,014,029
G
Lef1
lymphoid enhancer binding factor 1
affects expression
ISO
evodiamine affects the expression of LEF1 mRNA
CTD
PMID:31835579
NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:222,340,704...222,453,929
G
Lgmn
legumain
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of LGMN protein]
CTD
PMID:35362542
NCBI chr 6:127,308,913...127,347,355
Ensembl chr 6:127,308,913...127,347,328
G
Lrp5
LDL receptor related protein 5
decreases expression
ISO
evodiamine results in decreased expression of LRP5 mRNA
CTD
PMID:31835579
NCBI chr 1:210,243,499...210,346,886
Ensembl chr 1:210,243,502...210,346,822
G
Lrpap1
LDL receptor related protein associated protein 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of LRPAP1 protein]
CTD
PMID:35362542
NCBI chr14:79,876,002...79,888,011
Ensembl chr14:79,875,708...79,890,034
G
Lsm3
LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of LSM3 protein]
CTD
PMID:35362542
NCBI chr 4:125,578,185...125,584,429
Ensembl chr 4:125,578,185...125,584,429
G
Lsm4
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of LSM4 protein]
CTD
PMID:35362542
NCBI chr16:18,789,466...18,795,164
Ensembl chr16:18,789,467...18,794,886
G
Luc7l3
LUC7 pre-mRNA splicing factor like 3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of LUC7L3 protein]
CTD
PMID:35362542
NCBI chr10:79,737,457...79,773,478
Ensembl chr10:79,736,853...79,773,429
G
Macf1
microtubule-actin crosslinking factor 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of MACF1 protein]
CTD
PMID:35362542
NCBI chr 5:140,908,829...141,234,127
Ensembl chr 5:140,908,837...141,233,890
G
Man1a1
mannosidase, alpha, class 1A, member 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of MAN1A protein]
CTD
PMID:35362542
NCBI chr20:33,745,158...33,928,584
Ensembl chr20:33,745,165...33,928,584
G
Mapk1
mitogen activated protein kinase 1
multiple interactions decreases phosphorylation increases phosphorylation
ISO EXP
chelerythrine inhibits the reaction [evodiamine results in increased phosphorylation of MAPK1 protein]; EGFR mutant form inhibits the reaction [evodiamine results in increased phosphorylation of MAPK1 protein]; evodiamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; RTKI cpd inhibits the reaction [evodiamine results in increased phosphorylation of MAPK1 protein] evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] evodiamine results in decreased phosphorylation of MAPK1 protein evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; evodiamine results in decreased expression of and results in decreased phosphorylation of MAPK1 protein
CTD
PMID:17884939 PMID:19854188 PMID:28303407 PMID:34401976 PMID:39334374
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
G
Mapk13
mitogen activated protein kinase 13
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of MAPK13 protein]
CTD
PMID:35362542
NCBI chr20:6,836,979...6,847,197
Ensembl chr20:6,837,013...6,847,191
G
Mapk3
mitogen activated protein kinase 3
multiple interactions decreases phosphorylation increases phosphorylation
ISO EXP
chelerythrine inhibits the reaction [evodiamine results in increased phosphorylation of MAPK3 protein]; EGFR mutant form inhibits the reaction [evodiamine results in increased phosphorylation of MAPK3 protein]; evodiamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]; RTKI cpd inhibits the reaction [evodiamine results in increased phosphorylation of MAPK3 protein] evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; evodiamine results in decreased expression of and results in decreased phosphorylation of MAPK3 protein evodiamine results in decreased phosphorylation of MAPK3 protein
CTD
PMID:17884939 PMID:19854188 PMID:28303407 PMID:34401976 PMID:39334374
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions increases expression
ISO EXP
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [evodiamine results in increased expression of MAPK8 protein modified form] evodiamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein] evodiamine inhibits the reaction [Bortezomib results in increased phosphorylation of MAPK8 protein]
CTD
PMID:23774672 PMID:34401976 PMID:38010754
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
G
Mapk9
mitogen-activated protein kinase 9
multiple interactions increases expression
ISO
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [evodiamine results in increased expression of MAPK9 protein modified form]
CTD
PMID:23774672
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
G
Mcm3
minichromosome maintenance complex component 3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of MCM3 protein]
CTD
PMID:35362542
NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:30,715,602...30,733,746
G
Mecr
mitochondrial trans-2-enoyl-CoA reductase
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of MECR protein]
CTD
PMID:35362542
NCBI chr 5:149,313,765...149,339,964
Ensembl chr 5:149,313,774...149,342,825
G
Meis1
Meis homeobox 1
decreases expression
ISO
evodiamine results in decreased expression of MEIS1 mRNA
CTD
PMID:32057900
NCBI chr14:97,356,949...97,499,646
Ensembl chr14:97,322,748...97,495,083
G
Memo1
mediator of cell motility 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of MEMO1 protein]
CTD
PMID:35362542
NCBI chr 6:26,895,497...26,986,248
Ensembl chr 6:26,896,290...26,986,442
G
Met
MET proto-oncogene, receptor tyrosine kinase
increases expression multiple interactions
ISO
evodiamine results in increased expression of MET mRNA evodiamine inhibits the reaction [HGF protein results in increased phosphorylation of MET protein]; MET protein affects the reaction [evodiamine inhibits the reaction [HGF protein results in increased phosphorylation of SRC protein]]; MET protein affects the reaction [evodiamine inhibits the reaction [HGF protein results in increased phosphorylation of STAT3 protein]]
CTD
PMID:32183146 PMID:38878560
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:46,756,506...46,870,821
G
Mgat4c
MGAT4 family, member C
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of MGAT4C protein]
CTD
PMID:35362542
NCBI chr 7:38,596,117...39,361,103
Ensembl chr 7:38,596,065...39,362,078
G
Micu2
mitochondrial calcium uptake 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of MICU2 protein]
CTD
PMID:35362542
NCBI chr15:36,180,413...36,262,429
Ensembl chr15:36,170,832...36,262,686
G
Mien1
migration and invasion enhancer 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of MIEN1 protein]
CTD
PMID:35362542
NCBI chr10:83,931,485...83,932,778
Ensembl chr10:83,930,955...83,932,778
G
Mki67
marker of proliferation Ki-67
multiple interactions decreases expression
ISO
[evodiamine co-treated with tetramethylpyrazine] results in decreased expression of MKI67 protein evodiamine results in decreased expression of MKI67 protein
CTD
PMID:37611839 PMID:39486648
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
G
Mmp2
matrix metallopeptidase 2
decreases expression
ISO
evodiamine results in decreased expression of MMP2 protein
CTD
PMID:32425601
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
G
Mmp7
matrix metallopeptidase 7
decreases expression
ISO
evodiamine results in decreased expression of MMP7 protein
CTD
PMID:32425601
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755
G
Mmp9
matrix metallopeptidase 9
multiple interactions decreases expression
ISO
evodiamine inhibits the reaction [TNF protein results in increased expression of MMP9 protein]; HGF protein affects the reaction [evodiamine results in decreased expression of MMP9 protein]
CTD
PMID:15710601 PMID:32183146 PMID:32425601
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
G
Mob4
MOB family member 4, phocein
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of MOB4 protein]
CTD
PMID:35362542
NCBI chr 9:64,111,170...64,135,740
Ensembl chr 9:64,111,718...64,135,779
G
Mpo
myeloperoxidase
multiple interactions
ISO
evodiamine inhibits the reaction [Lipopolysaccharides results in increased activity of MPO protein]
CTD
PMID:34401976
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
G
Mpst
mercaptopyruvate sulfurtransferase
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of MPST protein]
CTD
PMID:35362542
NCBI chr 7:111,836,079...111,843,651
Ensembl chr 7:111,835,587...111,843,650
G
Mrpl22
mitochondrial ribosomal protein L22
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of MRPL22 protein]
CTD
PMID:35362542
NCBI chr10:42,843,165...42,856,243
Ensembl chr10:42,843,222...42,856,227
G
Msrb3
methionine sulfoxide reductase B3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of MSRB3 protein]
CTD
PMID:35362542
NCBI chr 7:58,188,827...58,311,459
Ensembl chr 7:57,968,124...58,311,116
G
Mst1
macrophage stimulating 1
increases expression multiple interactions
ISO
evodiamine results in increased expression of MST1 mRNA; evodiamine results in increased expression of MST1 protein XMU-MP-1 inhibits the reaction [evodiamine results in increased expression of MST1 mRNA]; XMU-MP-1 inhibits the reaction [evodiamine results in increased expression of MST1 protein]
CTD
PMID:32057900
NCBI chr 8:117,646,485...117,652,016
Ensembl chr 8:117,647,438...117,652,015
G
Mt-nd1
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ND1 protein]
CTD
PMID:35362542
NCBI chr MT:2,740...3,694
Ensembl chr MT:2,729...3,685
G
Mt-nd4
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ND4 protein]
CTD
PMID:35362542
NCBI chr MT:10,160...11,537
Ensembl chr MT:10,145...11,522
G
Mtor
mechanistic target of rapamycin kinase
decreases expression
ISO
evodiamine results in decreased expression of MTOR mRNA; evodiamine results in decreased expression of MTOR protein
CTD
PMID:34824590
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
G
Muc1
mucin 1, cell surface associated
decreases expression
ISO
evodiamine results in decreased expression of MUC1 mRNA; evodiamine results in decreased expression of MUC1 protein alternative form
CTD
PMID:33208183
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:176,933,047...176,938,491
G
Mvd
mevalonate diphosphate decarboxylase
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of MVD protein]
CTD
PMID:35362542
NCBI chr19:67,404,911...67,414,974
Ensembl chr19:67,404,911...67,422,366
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions increases expression decreases expression
ISO
evodiamine inhibits the reaction [TNF protein results in increased expression of MYC protein] evodiamine results in increased expression of MYC mRNA evodiamine results in decreased expression of MYC mRNA; evodiamine results in decreased expression of MYC protein
CTD
PMID:15710601 PMID:32057900 PMID:32425601 PMID:38878560
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
G
Myd88
MYD88, innate immune signal transduction adaptor
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of MYD88 protein]
CTD
PMID:35362542
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230
G
Myl4
myosin, light chain 4
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of MYL4 protein]
CTD
PMID:35362542
NCBI chr10:89,949,733...89,985,308
Ensembl chr10:89,949,404...89,985,308
G
Mzb1
marginal zone B and B1 cell-specific protein
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of MZB1 protein]
CTD
PMID:35362542
NCBI chr18:27,513,087...27,515,148
Ensembl chr18:27,513,089...27,515,182
G
Nagk
N-acetylglucosamine kinase
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of NAGK protein]
CTD
PMID:35362542
NCBI chr 4:117,838,761...117,846,304
Ensembl chr 4:117,838,826...117,847,836
G
Nanog
Nanog homeobox
increases expression
ISO
evodiamine results in increased expression of NANOG mRNA
CTD
PMID:31835579
NCBI chr 4:157,615,687...157,623,061
Ensembl chr 4:157,615,687...157,623,061
G
Napg
NSF attachment protein gamma
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of NAPG protein]
CTD
PMID:35362542
NCBI chr18:58,710,702...58,729,450
Ensembl chr18:58,708,655...58,729,450
G
Nf2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
decreases expression
ISO
evodiamine results in decreased expression of NF2 mRNA
CTD
PMID:32057900
NCBI chr14:83,850,894...83,934,263
Ensembl chr14:83,850,894...83,934,151
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
evodiamine inhibits the reaction [Hydrogen Peroxide results in increased activity of NFKB1 protein]; evodiamine inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein]; evodiamine inhibits the reaction [Okadaic Acid results in increased activity of NFKB1 protein]; evodiamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein]; evodiamine inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; evodiamine inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]
CTD
PMID:15710601
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [evodiamine results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; evodiamine inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; evodiamine inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; evodiamine results in increased phosphorylation of and results in increased degradation of NFKBIA protein; wortmannin inhibits the reaction [evodiamine results in increased phosphorylation of and results in increased degradation of NFKBIA protein] [APC protein mutant form affects the susceptibility to evodiamine] which affects the phosphorylation of NFKBIA protein; evodiamine inhibits the reaction [Dextran Sulfate results in increased phosphorylation of NFKBIA protein]
CTD
PMID:15710601 PMID:20005289 PMID:35362542
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
G
Ngf
nerve growth factor
multiple interactions
ISO
evodiamine inhibits the reaction [Imiquimod results in increased expression of NGF mRNA]; evodiamine inhibits the reaction [Imiquimod results in increased expression of NGF protein]
CTD
PMID:38948922
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
G
Nipsnap1
nipsnap homolog 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of NIPSNAP1 protein]
CTD
PMID:35362542
NCBI chr14:83,957,714...83,981,579
Ensembl chr14:83,957,702...83,981,576
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions
EXP
evodiamine inhibits the reaction [Uric Acid results in increased expression of NLRP3 protein]
CTD
PMID:37555854
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
G
Nme1
NME/NM23 nucleoside diphosphate kinase 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of NME1 protein]
CTD
PMID:35362542
NCBI chr10:79,403,939...79,426,620
Ensembl chr10:79,403,940...79,413,310
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
evodiamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; evodiamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD
PMID:17109845 PMID:34401976
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
G
Notch1
notch receptor 1
decreases expression
ISO
evodiamine results in decreased expression of NOTCH1 mRNA
CTD
PMID:31835579
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:29,676,171...29,721,613
G
Nup133
nucleoporin 133
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of NUP133 protein]
CTD
PMID:35362542
NCBI chr19:68,789,065...68,838,692
Ensembl chr19:68,789,065...68,838,692
G
Nup93
nucleoporin 93
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of NUP93 protein]
CTD
PMID:35362542
NCBI chr19:10,690,154...10,793,937
Ensembl chr19:10,687,115...10,793,380
G
Nxn
nucleoredoxin
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of NXN protein]
CTD
PMID:35362542
NCBI chr10:61,607,557...61,745,807
Ensembl chr10:61,607,568...61,745,807
G
Otc
ornithine transcarbamylase
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of OTC protein]
CTD
PMID:35362542
NCBI chr X:15,126,358...15,202,473
Ensembl chr X:15,126,358...15,239,555
G
Palm
paralemmin
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PALM protein]
CTD
PMID:35362542
NCBI chr 7:10,537,252...10,563,346
Ensembl chr 7:10,537,277...10,563,007
G
Pals1
protein associated with LIN7 1, MAGUK p55 family member
increases expression
ISO
evodiamine results in increased expression of MPP5 mRNA
CTD
PMID:32057900
NCBI chr 6:103,327,965...103,384,543
Ensembl chr 6:103,281,154...103,387,209
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases expression increases cleavage
ISO
[HGF protein co-treated with evodiamine] results in increased cleavage of PARP1 protein; EUK-134 inhibits the reaction [evodiamine results in increased cleavage of PARP1 protein]; evodiamine promotes the reaction [TNF protein results in increased cleavage of PARP1 protein]; Rotenone inhibits the reaction [evodiamine results in increased cleavage of PARP1 protein] evodiamine results in increased expression of PARP1 protein
CTD
PMID:15710601 PMID:32183146 PMID:32425601 PMID:33208183 PMID:34808100 PMID:35899176 More...
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
G
Parp9
poly (ADP-ribose) polymerase family, member 9
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of PARP9 protein]
CTD
PMID:35362542
NCBI chr11:78,286,282...78,320,409
Ensembl chr11:78,286,287...78,320,608
G
Pck1
phosphoenolpyruvate carboxykinase 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of PCK1 protein]
CTD
PMID:35362542
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561
G
Pcna
proliferating cell nuclear antigen
decreases expression
ISO
evodiamine results in decreased expression of PCNA protein
CTD
PMID:32425601 PMID:39334374
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
G
Pdcd4
programmed cell death 4
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of PDCD4 protein]
CTD
PMID:35362542
NCBI chr 1:262,912,659...262,949,581
Ensembl chr 1:262,926,656...262,950,189
G
Pdlim4
PDZ and LIM domain 4
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PDLIM4 protein]
CTD
PMID:35362542
NCBI chr10:38,699,444...38,713,696
Ensembl chr10:38,699,444...38,713,659
G
Pds5a
PDS5 cohesin associated factor A
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of PDS5A protein]
CTD
PMID:35362542
NCBI chr14:42,905,734...43,004,740
Ensembl chr14:42,905,328...43,004,740
G
Pea15
proliferation and apoptosis adaptor protein 15
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PEA15A protein]
CTD
PMID:35362542
NCBI chr13:87,190,189...87,199,811
Ensembl chr13:87,187,295...87,199,859
G
Pecam1
platelet and endothelial cell adhesion molecule 1
multiple interactions
ISO
evodiamine inhibits the reaction [TGFB1 protein results in decreased expression of PECAM1 protein]
CTD
PMID:28303407
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839
G
Pfdn2
prefoldin subunit 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PFDN2 protein]
CTD
PMID:35362542
NCBI chr13:86,305,037...86,323,008
G
Pfdn6
prefoldin subunit 6
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of PFDN6 protein]
CTD
PMID:35362542
NCBI chr20:4,947,844...4,949,318
Ensembl chr20:4,947,844...4,949,318
G
Pgrmc1
progesterone receptor membrane component 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PGRMC1 protein]
CTD
PMID:35362542
NCBI chr X:120,698,610...120,706,805
Ensembl chr X:120,698,610...120,706,805
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
decreases phosphorylation
ISO
evodiamine results in decreased phosphorylation of PIK3R1 protein
CTD
PMID:34824590
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
G
Pla2g4c
phospholipase A2 group IVC
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of PLA2G4C protein]
CTD
PMID:35362542
NCBI chr 1:83,315,017...83,411,342
Ensembl chr 1:83,382,068...83,410,037
G
Plcg1
phospholipase C, gamma 1
multiple interactions increases phosphorylation
ISO
EGFR mutant form inhibits the reaction [evodiamine results in increased phosphorylation of PLCG1 protein]
CTD
PMID:19854188
NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:169,804,846...169,836,050
G
Plcg2
phospholipase C, gamma 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PLCG2 protein]
CTD
PMID:35362542
NCBI chr19:62,456,196...62,592,684
Ensembl chr19:62,453,259...62,592,684
G
Plekho2
pleckstrin homology domain containing O2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PLEKHO2 protein]
CTD
PMID:35362542
NCBI chr 8:74,973,578...75,000,532
Ensembl chr 8:74,974,740...75,000,430
G
Pnpt1
polyribonucleotide nucleotidyltransferase 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PNPT1 protein]
CTD
PMID:35362542
NCBI chr14:107,078,486...107,109,628
Ensembl chr14:107,078,469...107,109,628
G
Polr2h
RNA polymerase II, I and III subunit H
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of POLR2H protein]
CTD
PMID:35362542
NCBI chr11:93,696,423...93,701,902
Ensembl chr10:105,353,444...105,354,241 Ensembl chr11:105,353,444...105,354,241
G
Potef-ps1
POTE ankyrin domain family, member F, pseudogene 1
increases expression
ISO
evodiamine results in increased expression of POTEF mRNA
CTD
PMID:32057900
NCBI chr18:23,900,710...24,602,964
G
Pou5f1
POU class 5 homeobox 1
multiple interactions
ISO
[evodiamine co-treated with tetramethylpyrazine] results in decreased expression of POU5F1 protein; [tetramethylpyrazine co-treated with evodiamine] inhibits the reaction [POU5F1 protein binds to ESR2 promoter]
CTD
PMID:39486648
NCBI chr20:3,227,836...3,232,598
Ensembl chr20:3,227,837...3,232,598
G
Pparg
peroxisome proliferator-activated receptor gamma
decreases expression multiple interactions
ISO
evodiamine results in decreased expression of PPARG evodiamine inhibits the reaction [Dietary Fats results in decreased expression of PPARG protein]
CTD
PMID:17884939 PMID:34902249
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
G
Ppic
peptidylprolyl isomerase C
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PPIC protein]
CTD
PMID:35362542
NCBI chr18:49,040,690...49,053,296
Ensembl chr18:49,040,692...49,053,466
G
Ppih
peptidylprolyl isomerase H
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of PPIH protein]
CTD
PMID:35362542
NCBI chr 5:138,191,624...138,209,625
Ensembl chr 5:138,191,624...138,209,580
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of PPP1R1B protein]
CTD
PMID:35362542
NCBI chr10:83,843,948...83,853,063
Ensembl chr10:83,844,036...83,853,063
G
Ppp2r5d
protein phosphatase 2, regulatory subunit B', delta
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of PPP2R5D protein]
CTD
PMID:35362542
NCBI chr 9:21,767,963...21,797,997
Ensembl chr 9:21,767,688...21,797,996
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PRKAA2 protein]
CTD
PMID:35362542
NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:125,042,179...125,108,324
G
Prkca
protein kinase C, alpha
multiple interactions increases phosphorylation
ISO
EGFR mutant form inhibits the reaction [evodiamine results in increased phosphorylation of PRKCA protein]; RTKI cpd inhibits the reaction [evodiamine results in increased phosphorylation of PRKCA protein]
CTD
PMID:19854188
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572
G
Prkg1
protein kinase cGMP-dependent 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of PRKG1 protein]
CTD
PMID:35362542
NCBI chr 1:237,818,950...239,052,184
Ensembl chr 1:237,823,053...239,103,005
G
Prom1
prominin 1
decreases expression
ISO
evodiamine results in decreased expression of PROM1 mRNA
CTD
PMID:31835579
NCBI chr14:71,202,303...71,307,008
Ensembl chr14:71,202,336...71,307,002
G
Prorsd1
prolyl-tRNA synthetase associated domain containing 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of PRORSD1 protein]
CTD
PMID:35362542
NCBI chr14:107,458,910...107,461,179
Ensembl chr14:107,458,857...107,461,205
G
Prpf4
pre-mRNA splicing tri-snRNP complex factor PRPF4
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PRPF4 protein]
CTD
PMID:35362542
NCBI chr 5:80,875,511...80,889,501
Ensembl chr 5:80,875,498...80,889,497
G
Pten
phosphatase and tensin homolog
increases expression
ISO
evodiamine results in increased expression of PTEN mRNA; evodiamine results in increased expression of PTEN protein
CTD
PMID:34824590
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330
G
Ptger3
prostaglandin E receptor 3
multiple interactions
ISO
[evodiamine co-treated with tetramethylpyrazine] results in decreased expression of PTGER3 mRNA
CTD
PMID:39486648
NCBI chr 2:249,264,985...249,409,966
Ensembl chr 2:249,264,985...249,409,846
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions decreases expression
ISO
evodiamine inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]; HGF protein affects the reaction [evodiamine results in decreased expression of PTGS2 protein] evodiamine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; evodiamine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
CTD
PMID:15710601 PMID:32183146 PMID:34401976
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
G
Pycard
PYD and CARD domain containing
multiple interactions
EXP
evodiamine inhibits the reaction [Uric Acid results in increased expression of PYCARD protein]
CTD
PMID:37555854
NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:192,032,124...192,033,419
G
Rab1b
RAB1B, member RAS oncogene family
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of RAB1B protein]
CTD
PMID:35362542
NCBI chr 1:211,835,133...211,843,408
Ensembl chr 1:211,835,073...211,843,337 Ensembl chr X:211,835,073...211,843,337
G
Rab32
RAB32, member RAS oncogene family
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of RAB32 protein]
CTD
PMID:35362542
NCBI chr 1:6,766,448...6,781,258
Ensembl chr 1:6,766,455...6,781,258
G
Rab4b
RAB4B, member RAS oncogene family
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of RAB4B protein]
CTD
PMID:35362542
NCBI chr 1:91,589,047...91,600,426
Ensembl chr 1:91,589,047...91,600,337
G
Ranbp3
RAN binding protein 3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of RANBP3 protein]
CTD
PMID:35362542
NCBI chr 9:1,594,344...1,631,587
Ensembl chr 9:1,594,346...1,631,587
G
Rbm47
RNA binding motif protein 47
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of RBM47 protein]
CTD
PMID:35362542
NCBI chr14:42,407,226...42,545,304
Ensembl chr14:42,466,335...42,543,163
G
Rbpms
RNA binding protein, mRNA processing factor
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of RBPMS protein]
CTD
PMID:35362542
NCBI chr16:64,942,159...65,098,504
Ensembl chr16:64,942,530...65,098,503
G
Rcn3
reticulocalbin 3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of RCN3 protein]
CTD
PMID:35362542
NCBI chr 1:104,700,969...104,710,228
Ensembl chr 1:104,700,545...104,710,249
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions decreases phosphorylation
ISO
evodiamine inhibits the reaction [Hydrogen Peroxide results in increased activity of RELA protein]; evodiamine inhibits the reaction [IL1B protein results in increased activity of RELA protein]; evodiamine inhibits the reaction [IL6 protein results in increased phosphorylation of RELA protein]; evodiamine inhibits the reaction [Okadaic Acid results in increased activity of RELA protein]; evodiamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of RELA protein]; evodiamine inhibits the reaction [TNF protein affects the localization of RELA protein]; evodiamine inhibits the reaction [TNF protein results in increased acetylation of RELA protein]; evodiamine inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; evodiamine inhibits the reaction [TNF protein results in increased activity of RELA protein]; evodiamine results in decreased phosphorylation of and affects the localization of RELA protein evodiamine results in decreased phosphorylation of RELA protein [APC protein mutant form affects the susceptibility to evodiamine] which affects the phosphorylation of RELA protein; evodiamine inhibits the reaction [Dextran Sulfate results in increased phosphorylation of RELA protein]; evodiamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]
CTD
PMID:15710601 PMID:33277208 PMID:34401976 PMID:35362542 PMID:35899176
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
G
Rer1
retention in endoplasmic reticulum sorting receptor 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of RER1 protein]
CTD
PMID:35362542
NCBI chr 5:170,916,643...170,929,073
Ensembl chr 5:170,916,905...170,928,980
G
Rexo2
RNA exonuclease 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of REXO2 protein]
CTD
PMID:35362542
NCBI chr 8:57,708,420...57,720,142
Ensembl chr 8:57,707,558...57,720,142
G
Rgs10
regulator of G-protein signaling 10
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of RGS10 protein]
CTD
PMID:35362542
NCBI chr 1:192,376,772...192,422,640
Ensembl chr 1:192,376,774...192,418,904
G
Rnasel
ribonuclease L
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of RNASEL protein]
CTD
PMID:35362542
NCBI chr13:68,446,641...68,460,804
Ensembl chr13:68,446,882...68,459,557
G
Rpl13a
ribosomal protein L13A
decreases expression
ISO
evodiamine results in decreased expression of RPL13A mRNA
CTD
PMID:32057900
NCBI chr 1:104,746,223...104,748,975
Ensembl chr 1:104,746,223...104,748,914
G
Rps15
ribosomal protein S15
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of RPS15 protein]
CTD
PMID:35362542
NCBI chr 7:10,066,572...10,068,167
Ensembl chr 7:10,066,677...10,068,123
G
Rps21-ps1
ribosomal protein S21, pseudogene 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of RPS21 protein]
CTD
PMID:35362542
NCBI chr 5:158,670,141...158,670,484
Ensembl chr 5:158,670,116...158,670,490
G
RT1-Ba
RT1 class II, locus Ba
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of H2-AA protein]
CTD
PMID:35362542
NCBI chr20:4,577,057...4,581,650
Ensembl chr20:4,576,843...4,581,653
G
S100a4
S100 calcium-binding protein A4
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of S100A4 protein]
CTD
PMID:35362542
NCBI chr 2:178,388,529...178,390,838
Ensembl chr 2:178,388,526...178,390,837
G
S100a9
S100 calcium binding protein A9
multiple interactions
ISO
[APC protein mutant form affects the susceptibility to evodiamine] which affects the expression of S100A9 protein; evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of S100A9 protein]; evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of S100A9 protein]
CTD
PMID:35362542
NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:178,487,941...178,490,870
G
Sav1
salvador family WW domain containing protein 1
increases expression
ISO
evodiamine results in increased expression of SAV1 mRNA
CTD
PMID:32057900
NCBI chr 6:94,214,514...94,236,354
Ensembl chr 6:94,214,517...94,235,945
G
Scd
stearoyl-CoA desaturase
affects expression
ISO
evodiamine affects the expression of SCD mRNA
CTD
PMID:31835579
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
G
Scrib
scribble planar cell polarity protein
increases expression
ISO
evodiamine results in increased expression of SCRIB mRNA
CTD
PMID:32057900
NCBI chr 7:109,640,034...109,663,354
Ensembl chr 7:109,640,034...109,663,022
G
Sema3a
semaphorin 3A
multiple interactions increases expression
ISO
evodiamine inhibits the reaction [Lactic Acid results in decreased expression of SEMA3A mRNA]; evodiamine inhibits the reaction [Lactic Acid results in decreased expression of SEMA3A protein]; ferrostatin-1 inhibits the reaction [evodiamine results in increased expression of SEMA3A protein]
CTD
PMID:37611839
NCBI chr 4:22,239,418...22,709,907
Ensembl chr 4:22,245,322...22,535,774
G
Sf1
splicing factor 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SF1 protein]
CTD
PMID:35362542
NCBI chr 1:213,090,256...213,112,688
Ensembl chr 1:213,099,260...213,113,590
G
Sgcd
sarcoglycan, delta
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of SGCD protein]
CTD
PMID:35362542
NCBI chr10:31,847,713...32,829,554
Ensembl chr10:31,781,748...32,419,064
G
Shmt1
serine hydroxymethyltransferase 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SHMT1 protein]
CTD
PMID:35362542
NCBI chr10:45,968,959...45,990,341
Ensembl chr10:45,960,434...45,997,326
G
Sirt2
sirtuin 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of SIRT2 protein]
CTD
PMID:35362542
NCBI chr 1:93,181,472...93,204,499
Ensembl chr 1:93,181,224...93,204,499
G
Skic3
SKI3 subunit of superkiller complex
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SKIC3 protein]
CTD
PMID:35362542
NCBI chr 2:7,363,417...7,526,351
Ensembl chr 2:7,363,535...7,483,496
G
Slc12a2
solute carrier family 12 member 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SLC12A2 protein]
CTD
PMID:35362542
NCBI chr18:53,546,263...53,614,478
Ensembl chr18:53,546,333...53,614,470
G
Slc22a18
solute carrier family 22, member 18
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of SLC22A18 protein]
CTD
PMID:35362542
NCBI chr 1:208,100,032...208,124,382
Ensembl chr 1:208,101,136...208,124,380
G
Slc25a13
solute carrier family 25 member 13
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of SLC25A13 protein]
CTD
PMID:35362542
NCBI chr 4:35,145,721...35,328,403
Ensembl chr 4:35,145,721...35,328,360
G
Slc30a7
solute carrier family 30 member 7
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of SLC30A7 protein]
CTD
PMID:35362542
NCBI chr 2:206,544,800...206,607,087
Ensembl chr 2:206,544,800...206,607,043
G
Slc35a1
solute carrier family 35 member A1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SLC35A1 protein]
CTD
PMID:35362542
NCBI chr 5:54,021,896...54,044,677
Ensembl chr 5:54,021,896...54,044,677
G
Slc4a7
solute carrier family 4 member 7
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SLC4A7 protein]
CTD
PMID:35362542
NCBI chr15:13,015,854...13,095,485
Ensembl chr15:13,015,854...13,095,292
G
Smad2
SMAD family member 2
multiple interactions
ISO EXP
evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of SMAD2 protein]
CTD
PMID:28303407
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388
G
Smad3
SMAD family member 3
multiple interactions
EXP ISO
evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of SMAD3 protein]
CTD
PMID:28303407
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
G
Smad4
SMAD family member 4
multiple interactions
EXP ISO
evodiamine inhibits the reaction [TGFB1 protein affects the localization of SMAD4 protein] evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SMAD4 protein]
CTD
PMID:28303407 PMID:35362542
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:69,518,988...69,549,684
G
Smarcb1
SWI/SNF related BAF chromatin remodeling complex subunit B1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SMARCB1 protein]
CTD
PMID:35362542
NCBI chr20:12,740,105...12,763,054
Ensembl chr20:12,740,943...12,763,055
G
Smarce1
SWI/SNF related BAF chromatin remodeling complex subunit E1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SMARCE1 protein]
CTD
PMID:35362542
NCBI chr10:84,655,468...84,678,259
Ensembl chr10:84,655,468...84,676,185
G
Smo
smoothened, frizzled class receptor
increases expression
ISO
evodiamine results in increased expression of SMO mRNA
CTD
PMID:31835579
NCBI chr 4:59,311,084...59,341,280
Ensembl chr 4:59,311,041...59,341,281
G
Smpd3
sphingomyelin phosphodiesterase 3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SMPD3 protein]
CTD
PMID:35362542
NCBI chr19:51,072,209...51,155,639
Ensembl chr19:51,072,209...51,085,936
G
Smpdl3a
sphingomyelin phosphodiesterase, acid-like 3A
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of SMPDL3A protein]
CTD
PMID:35362542
NCBI chr20:37,679,004...37,701,979
Ensembl chr20:37,678,964...37,704,260
G
Snai1
snail family transcriptional repressor 1
decreases expression
ISO
evodiamine results in decreased expression of SNAI1 protein
CTD
PMID:32425601
NCBI chr 3:176,667,476...176,671,965
G
Snrpf
small nuclear ribonucleoprotein polypeptide F
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of SNRPF protein]
CTD
PMID:35362542
NCBI chr 7:30,017,460...30,024,162
Ensembl chr 7:30,017,460...30,024,162
G
Snrpg
small nuclear ribonucleoprotein polypeptide G
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of SNRPG protein]
CTD
PMID:35362542
NCBI chr 4:120,369,676...120,377,263
Ensembl chr 4:120,369,685...120,377,261 Ensembl chr X:120,369,685...120,377,261
G
Spink1
serine peptidase inhibitor, Kazal type 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SPINK1 protein]
CTD
PMID:35362542
NCBI chr18:36,121,626...36,133,596
Ensembl chr18:36,076,399...36,133,545
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
decreases expression multiple interactions
ISO
evodiamine results in decreased expression of SRC protein evodiamine inhibits the reaction [Dihydrotestosterone promotes the reaction [SRC protein binds to AR protein]]; evodiamine inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of SRC protein]; evodiamine inhibits the reaction [HGF protein results in increased phosphorylation of SRC protein]; MET protein affects the reaction [evodiamine inhibits the reaction [HGF protein results in increased phosphorylation of SRC protein]]
CTD
PMID:32183146 PMID:34713388 PMID:39334374
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
G
Srrm2
serine/arginine repetitive matrix 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SRRM2 protein]
CTD
PMID:35362542
NCBI chr10:13,320,059...13,353,337
Ensembl chr10:13,320,059...13,353,337
G
Srsf11
serine and arginine rich splicing factor 11
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SRSF11 protein]
CTD
PMID:35362542
NCBI chr 2:249,733,464...249,760,296
Ensembl chr 2:249,733,464...249,760,499
G
St3gal6
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ST3GAL6 protein]
CTD
PMID:35362542
NCBI chr11:55,530,120...55,590,950
Ensembl chr11:55,530,248...55,598,720
G
Stat1
signal transducer and activator of transcription 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of STAT1 protein]
CTD
PMID:35362542
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346
G
Stat3
signal transducer and activator of transcription 3
decreases phosphorylation multiple interactions
ISO
evodiamine results in decreased phosphorylation of STAT3 protein evodiamine inhibits the reaction [HGF protein results in increased phosphorylation of and affects the localization of STAT3 protein]; evodiamine inhibits the reaction [IL6 protein affects the localization of STAT3 protein]; evodiamine inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein]; MET protein affects the reaction [evodiamine inhibits the reaction [HGF protein results in increased phosphorylation of STAT3 protein]]
CTD
PMID:32183146 PMID:33277208
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
G
Stk3
serine/threonine kinase 3
decreases expression multiple interactions increases expression
ISO
evodiamine results in decreased expression of STK3 mRNA XMU-MP-1 inhibits the reaction [evodiamine results in increased expression of STK3 mRNA] evodiamine results in increased expression of STK3 protein
CTD
PMID:32057900
NCBI chr 7:67,938,341...68,208,472
Ensembl chr 7:67,938,378...68,208,508
G
Sun1
Sad1 and UNC84 domain containing 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SUN1 protein]
CTD
PMID:35362542
NCBI chr12:20,510,230...20,555,123
Ensembl chr12:20,490,861...20,555,240
G
Susd2
sushi domain containing 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SUSD2 protein]
CTD
PMID:35362542
NCBI chr20:13,016,960...13,024,264
Ensembl chr20:13,016,907...13,024,264
G
Syne2
spectrin repeat containing nuclear envelope protein 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SYNE2 protein]
CTD
PMID:35362542
NCBI chr 6:100,272,729...100,586,364
Ensembl chr 6:100,272,729...100,583,723
G
Syvn1
synoviolin 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SYVN1 protein]
CTD
PMID:35362542
NCBI chr 1:212,766,736...212,775,426
Ensembl chr 1:212,768,907...212,776,457
G
Tac1
tachykinin, precursor 1
multiple interactions
ISO
evodiamine inhibits the reaction [Imiquimod results in increased expression of TAC1 mRNA]; evodiamine inhibits the reaction [Imiquimod results in increased expression of TAC1 protein]
CTD
PMID:38948922
NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:36,645,571...36,653,546
G
Taok1
TAO kinase 1
increases expression
ISO
evodiamine results in increased expression of TAOK1 mRNA
CTD
PMID:32057900
NCBI chr10:62,871,198...62,989,049
Ensembl chr10:62,871,198...62,957,595
G
Taok3
TAO kinase 3
decreases expression
ISO
evodiamine results in decreased expression of TAOK3 mRNA
CTD
PMID:32057900
NCBI chr12:44,973,180...45,134,439
Ensembl chr12:44,973,180...45,134,439
G
Tap1
transporter 1, ATP binding cassette subfamily B member
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of TAP1 protein]
CTD
PMID:35362542
NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,658,172...4,668,810
G
Tbl2
transducin (beta)-like 2
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of TBL2 protein]
CTD
PMID:35362542
NCBI chr12:27,154,150...27,168,446
Ensembl chr12:27,154,150...27,168,446
G
Tead1
TEA domain transcription factor 1
increases expression
ISO
evodiamine results in increased expression of TEAD1 mRNA
CTD
PMID:32057900
NCBI chr 1:176,227,175...176,445,122
Ensembl chr 1:176,227,175...176,438,198
G
Tgfa
transforming growth factor alpha
increases expression
ISO
evodiamine results in increased expression of TGFA mRNA
CTD
PMID:38878560
NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:120,175,593...120,258,339
G
Tgfb1
transforming growth factor, beta 1
multiple interactions increases expression
ISO EXP
evodiamine inhibits the reaction [TGFB1 protein affects the localization of SMAD4 protein]; evodiamine inhibits the reaction [TGFB1 protein results in decreased expression of CD34 protein]; evodiamine inhibits the reaction [TGFB1 protein results in decreased expression of PECAM1 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased expression of VIM protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of AKT1 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of SMAD2 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of SMAD3 protein] evodiamine results in increased expression of TGFB1 mRNA evodiamine inhibits the reaction [TGFB1 protein affects the localization of SMAD4 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased expression of CCN2 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of AKT1 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of SMAD2 protein]; evodiamine inhibits the reaction [TGFB1 protein results in increased phosphorylation of and results in increased activity of SMAD3 protein]
CTD
PMID:28303407 PMID:32057900
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
G
Tgm3
transglutaminase 3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of TGM3 protein]
CTD
PMID:35362542
NCBI chr 3:137,681,809...137,717,219
Ensembl chr 3:137,681,809...137,717,219
G
Thbs1
thrombospondin 1
increases expression
ISO
evodiamine results in increased expression of THBS1 mRNA
CTD
PMID:38878560
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of TLR4 protein]
CTD
PMID:35362542
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
G
Tmem30b
transmembrane protein 30B
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of TMEM30B protein]
CTD
PMID:35362542
NCBI chr 6:97,987,471...97,990,546
Ensembl chr 6:97,987,130...97,991,170
G
Tmsb10
thymosin, beta 10
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of TMSB10 protein]
CTD
PMID:35362542
NCBI chr 4:106,568,080...106,569,210
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
[evodiamine co-treated with tetramethylpyrazine] results in decreased expression of TNF mRNA; [evodiamine co-treated with tetramethylpyrazine] results in decreased secretion of TNF protein; evodiamine inhibits the reaction [TNF protein affects the localization of RELA protein]; evodiamine inhibits the reaction [TNF protein results in increased acetylation of RELA protein]; evodiamine inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; evodiamine inhibits the reaction [TNF protein results in increased activity of AKT1 protein]; evodiamine inhibits the reaction [TNF protein results in increased activity of CHUK protein]; evodiamine inhibits the reaction [TNF protein results in increased activity of IKBKB protein]; evodiamine inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]; evodiamine inhibits the reaction [TNF protein results in increased activity of RELA protein]; evodiamine inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of ABCB1 protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of BCL2 protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of BIRC2 protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of BIRC3 protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of BIRC5 protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of CCND1 protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of CFLAR protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of MMP9 protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of MYC protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of XIAP protein]; evodiamine inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; evodiamine promotes the reaction [TNF protein results in increased cleavage of PARP1 protein] [APC protein mutant form affects the susceptibility to evodiamine] which affects the expression of TNF protein; evodiamine inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF mRNA]; evodiamine inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]; evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; evodiamine inhibits the reaction [Imiquimod results in increased expression of TNF protein]; evodiamine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; evodiamine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] evodiamine inhibits the reaction [Uric Acid results in increased expression of TNF protein]
CTD
PMID:15710601 PMID:34218553 PMID:34401976 PMID:35362542 PMID:37555854 PMID:38948922 PMID:39486648 More...
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
Tomm5
translocase of outer mitochondrial membrane 5
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of TOMM5 protein]
CTD
PMID:35362542
NCBI chr 5:64,158,026...64,160,857
G
Top1
DNA topoisomerase I
multiple interactions
ISO
evodiamine binds to and results in decreased activity of TOP1 protein
CTD
PMID:26207989
NCBI chr 3:169,713,195...169,796,330
Ensembl chr 3:169,713,130...169,796,327
G
Tp53
tumor protein p53
increases expression multiple interactions
ISO
evodiamine results in increased expression of TP53 protein XMU-MP-1 inhibits the reaction [evodiamine results in increased expression of TP53 protein]
CTD
PMID:32057900
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
G
Tp63
tumor protein p63
decreases expression
ISO
evodiamine results in decreased expression of TP63 mRNA
CTD
PMID:32057900
NCBI chr11:88,343,647...88,554,543
Ensembl chr11:88,343,651...88,554,177
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
multiple interactions increases expression
ISO
evodiamine inhibits the reaction [Imiquimod results in increased expression of TRPV1 mRNA]; evodiamine inhibits the reaction [Imiquimod results in increased expression of TRPV1 protein] evodiamine results in increased expression of TRPV1 mRNA; evodiamine results in increased expression of TRPV1 protein
CTD
PMID:38878560 PMID:38948922
NCBI chr10:58,349,936...58,375,021
Ensembl chr10:58,340,223...58,375,021
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
multiple interactions
ISO
evodiamine inhibits the reaction [Imiquimod results in increased expression of TRPV3 mRNA]; evodiamine inhibits the reaction [Imiquimod results in increased expression of TRPV3 protein]
CTD
PMID:38948922
NCBI chr10:58,382,054...58,413,657
Ensembl chr10:58,382,054...58,411,800
G
Trpv4
transient receptor potential cation channel, subfamily V, member 4
multiple interactions
ISO
evodiamine inhibits the reaction [Imiquimod results in increased expression of TRPV4 mRNA]; evodiamine inhibits the reaction [Imiquimod results in increased expression of TRPV4 protein]
CTD
PMID:38948922
NCBI chr12:47,599,161...47,638,143
Ensembl chr12:47,599,035...47,638,143
G
Tsfm
Ts translation elongation factor, mitochondrial
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of TSFM protein]
CTD
PMID:35362542
NCBI chr 7:64,714,330...64,750,106
Ensembl chr 7:64,714,036...64,750,171
G
Tshz1
teashirt zinc finger homeobox 1
decreases expression
ISO
evodiamine results in decreased expression of TSHZ1 mRNA
CTD
PMID:32057900
NCBI chr18:79,651,256...79,727,662
Ensembl chr18:79,651,256...79,727,662
G
Twist2
twist family bHLH transcription factor 2
increases expression
ISO
evodiamine results in increased expression of TWIST2 mRNA
CTD
PMID:31835579
NCBI chr 9:99,822,242...99,866,722
Ensembl chr 9:99,818,962...99,920,270
G
Txndc9
thioredoxin domain containing 9
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of TXNDC9 protein]
CTD
PMID:35362542
NCBI chr 9:47,707,628...47,717,761
Ensembl chr 9:47,707,231...47,880,085
G
Txnip
thioredoxin interacting protein
multiple interactions
EXP
evodiamine inhibits the reaction [Uric Acid results in increased expression of TXNIP protein]
CTD
PMID:37555854
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731
G
Uba7
ubiquitin-like modifier activating enzyme 7
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of UBA7 protein]
CTD
PMID:35362542
NCBI chr 8:117,543,902...117,552,709
Ensembl chr 8:117,543,957...117,556,142
G
Ube2d3
ubiquitin-conjugating enzyme E2D 3
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of UBE2D3 protein]
CTD
PMID:35362542
NCBI chr 2:226,543,194...226,571,001
Ensembl chr 2:226,540,531...226,573,144
G
Ublcp1
ubiquitin-like domain containing CTD phosphatase 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of UBLCP1 protein]
CTD
PMID:35362542
NCBI chr10:29,447,081...29,462,446
Ensembl chr10:29,447,081...29,462,386
G
Ubtf
upstream binding transcription factor
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of UBTF protein]
CTD
PMID:35362542
NCBI chr10:87,758,346...87,775,377
Ensembl chr10:87,758,346...87,773,088
G
Upp1
uridine phosphorylase 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of UPP1 protein]
CTD
PMID:35362542
NCBI chr14:88,023,155...88,043,036
Ensembl chr14:88,023,351...88,043,034
G
Urod
uroporphyrinogen decarboxylase
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of UROD protein]
CTD
PMID:35362542
NCBI chr 5:135,701,294...135,705,380
Ensembl chr 5:135,701,296...135,705,380
G
Vegfa
vascular endothelial growth factor A
increases expression decreases expression
ISO
evodiamine results in increased expression of VEGFA mRNA evodiamine results in decreased expression of VEGFA protein
CTD
PMID:32183146 PMID:38878560
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
G
Vim
vimentin
multiple interactions decreases expression
ISO
evodiamine inhibits the reaction [TGFB1 protein results in increased expression of VIM protein] evodiamine results in decreased expression of VIM protein
CTD
PMID:28303407 PMID:32425601
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
G
Vps26c
VPS26 endosomal protein sorting factor C
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of VPS26C protein]
CTD
PMID:35362542
NCBI chr11:47,283,764...47,311,105
Ensembl chr11:47,262,071...47,311,045
G
Wasl
WASP like actin nucleation promoting factor
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of WASL protein]
CTD
PMID:35362542
NCBI chr 4:54,049,081...54,097,653
Ensembl chr 4:54,049,082...54,097,570
G
Wdr5
WD repeat domain 5
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of WDR5 protein]
CTD
PMID:35362542
NCBI chr 3:31,233,048...31,254,730
Ensembl chr 3:31,235,222...31,254,727
G
Xdh
xanthine dehydrogenase
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of XDH protein]
CTD
PMID:35362542
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
G
Xiap
X-linked inhibitor of apoptosis
multiple interactions decreases expression
ISO
evodiamine inhibits the reaction [EGF protein results in increased expression of XIAP protein]; evodiamine inhibits the reaction [TNF protein results in increased expression of XIAP protein] evodiamine results in decreased expression of XIAP protein
CTD
PMID:15710601 PMID:39334374
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:125,737,971...125,803,978
G
Xpnpep1
X-prolyl aminopeptidase 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of XPNPEP1 protein]
CTD
PMID:35362542
NCBI chr 1:262,006,761...262,057,479
Ensembl chr 1:262,006,761...262,092,425
G
Yap1
Yes1 associated transcriptional regulator
decreases expression multiple interactions
ISO
evodiamine results in decreased expression of YAP1 mRNA; evodiamine results in decreased expression of YAP1 protein evodiamine results in increased phosphorylation of and affects the localization of YAP1 protein; XMU-MP-1 inhibits the reaction [evodiamine results in decreased expression of YAP1 mRNA]; XMU-MP-1 inhibits the reaction [evodiamine results in decreased expression of YAP1 protein]; XMU-MP-1 inhibits the reaction [evodiamine results in increased phosphorylation of YAP1 protein]
CTD
PMID:32057900
NCBI chr 8:13,380,551...13,451,640
Ensembl chr 8:13,380,551...13,451,437
G
Ywhag
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma
increases expression
ISO
evodiamine results in increased expression of YWHAG mRNA
CTD
PMID:38878560
NCBI chr12:26,381,106...26,409,466
Ensembl chr12:26,380,816...26,409,465
G
Ywhaq
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
increases expression
ISO
evodiamine results in increased expression of YWHAQ mRNA
CTD
PMID:32057900
NCBI chr 6:46,664,358...46,694,875
Ensembl chr 6:46,664,358...46,694,875
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
increases expression
ISO
evodiamine results in increased expression of YWHAZ mRNA
CTD
PMID:32057900 PMID:38878560
NCBI chr 7:69,826,404...69,848,702
Ensembl chr 7:69,826,404...69,849,007
G
Zbp1
Z-DNA binding protein 1
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ZBP1 protein]
CTD
PMID:35362542
NCBI chr 3:182,411,665...182,427,604
Ensembl chr 3:182,411,665...182,422,839
G
Zdhhc18
zinc finger DHHC-type palmitoyltransferase 18
increases expression
ISO
evodiamine results in increased expression of ZDHHC18 mRNA
CTD
PMID:32057900
NCBI chr 5:151,105,303...151,143,843
Ensembl chr 5:151,105,201...151,143,769
G
Zfp422
zinc finger protein 422
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ZFP422 protein]
CTD
PMID:35362542
NCBI chr 4:151,558,254...151,565,730
Ensembl chr 4:151,556,738...151,566,152
G
Zg16
zymogen granule protein 16
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ZG16 protein]
CTD
PMID:35362542
NCBI chr 1:191,088,248...191,090,605
Ensembl chr 1:191,088,248...191,090,605
G
Zmpste24
zinc metallopeptidase STE24
multiple interactions
ISO
evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ZMPSTE24 protein]
CTD
PMID:35362542
NCBI chr 5:139,912,395...139,945,532
Ensembl chr 5:139,913,671...139,945,532
G
Adrb1
adrenoceptor beta 1
multiple interactions
ISO
Harmaline affects the reaction [Epinephrine results in increased activity of ADRB1 protein]
CTD
PMID:30155694
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237
G
Adrb2
adrenoceptor beta 2
multiple interactions
ISO
Harmaline inhibits the reaction [Epinephrine results in increased activity of ADRB2 protein]
CTD
PMID:30155694
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
Harmaline inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]
CTD
PMID:12107048
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
G
Cdh1
cadherin 1
increases expression
ISO
Harmaline results in increased expression of CDH1 protein
CTD
PMID:35963316
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions decreases activity decreases stability
ISO
[Cycloheximide co-treated with Harmaline] results in decreased expression of CYP1A1 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Cycloheximide co-treated with Harmaline] results in decreased expression of CYP1A1 protein]; Harmaline inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein]; Harmaline inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; Harmaline inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] Harmaline results in decreased activity of CYP1A1 protein Harmaline results in decreased stability of CYP1A1 protein
CTD
PMID:22037238
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Eng
endoglin
decreases expression multiple interactions
ISO
Harmaline results in decreased expression of ENG mRNA Doxorubicin promotes the reaction [Harmaline results in decreased expression of ENG mRNA]
CTD
PMID:35963316
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933
G
Ifng
interferon gamma
increases secretion
ISO
Harmaline results in increased secretion of IFNG protein
CTD
PMID:35963316
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Harmaline inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]]; Harmaline inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein]
CTD
PMID:12065299
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Il4
interleukin 4
affects secretion multiple interactions
ISO
Harmaline affects the secretion of IL4 protein Doxorubicin affects the reaction [Harmaline results in decreased secretion of IL4 protein]
CTD
PMID:35963316
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
G
Kdr
kinase insert domain receptor
multiple interactions decreases expression
ISO
Doxorubicin promotes the reaction [Harmaline results in decreased expression of KDR mRNA]
CTD
PMID:35963316
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192
G
Maoa
monoamine oxidase A
decreases activity
EXP ISO
Harmaline results in decreased activity of MAOA protein
CTD
PMID:15178694 PMID:24373881 PMID:28302559
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
G
Mki67
marker of proliferation Ki-67
decreases expression
ISO
Harmaline results in decreased expression of MKI67 protein
CTD
PMID:35963316
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
G
Mmp2
matrix metallopeptidase 2
decreases expression
ISO
Harmaline results in decreased expression of MMP2 protein
CTD
PMID:35963316
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
Harmaline inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]]; Harmaline inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein]
CTD
PMID:12065299 PMID:12107048
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions decreases expression
ISO
Doxorubicin promotes the reaction [Harmaline results in decreased expression of PTGS2 mRNA]
CTD
PMID:35963316
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
Harmaline inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]]; Harmaline inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of RELA protein]
CTD
PMID:12065299 PMID:12107048
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
G
Vegfa
vascular endothelial growth factor A
multiple interactions decreases expression
ISO
Doxorubicin promotes the reaction [Harmaline results in decreased expression of VEGFA mRNA] Harmaline results in decreased expression of VEGFA mRNA; Harmaline results in decreased expression of VEGFA protein
CTD
PMID:35963316
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
G
Casp3
caspase 3
increases activity increases expression
ISO
harmalol results in increased activity of CASP3 protein harmalol results in increased expression of CASP3 mRNA
CTD
PMID:27590872
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions decreases stability decreases activity
ISO
[Cycloheximide co-treated with harmalol] results in decreased expression of CYP1A1 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Cycloheximide co-treated with harmalol] results in decreased expression of CYP1A1 protein]; harmalol inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein]; harmalol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; harmalol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] harmalol results in decreased stability of CYP1A1 protein harmalol results in decreased activity of CYP1A1 protein
CTD
PMID:22037238
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Tp53
tumor protein p53
increases expression
ISO
harmalol results in increased expression of TP53 mRNA; harmalol results in increased expression of TP53 protein
CTD
PMID:27590872
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
AHR mutant form inhibits the reaction [harman results in increased activity of CYP1A1 protein]; AHR mutant form inhibits the reaction [harman results in increased expression of CYP1A1 protein]
CTD
PMID:20732341
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
G
Casp3
caspase 3
increases cleavage increases expression
ISO
harman results in increased cleavage of CASP3 protein harman results in increased expression of CASP3 mRNA
CTD
PMID:35985368
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Casp7
caspase 7
increases expression
ISO
harman results in increased expression of CASP7 mRNA
CTD
PMID:35985368
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
G
Casp9
caspase 9
increases expression
ISO
harman results in increased expression of CASP9 mRNA
CTD
PMID:35985368
Ensembl chr 5:159,391,188...159,409,648
G
Cat
catalase
decreases activity
ISO
harman results in decreased activity of CAT protein
CTD
PMID:35985368
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression increases activity
ISO EXP
AHR mutant form inhibits the reaction [harman results in increased activity of CYP1A1 protein]; AHR mutant form inhibits the reaction [harman results in increased expression of CYP1A1 protein]; Dactinomycin inhibits the reaction [harman results in increased expression of CYP1A1 mRNA]; resveratrol inhibits the reaction [harman results in increased activity of CYP1A1 protein] harman results in increased expression of CYP1A1 mRNA; harman results in increased expression of CYP1A1 protein
CTD
PMID:20732341
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Hmox1
heme oxygenase 1
increases expression
ISO
harman results in increased expression of HMOX1 mRNA
CTD
PMID:35985368
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
G
Maoa
monoamine oxidase A
decreases activity
ISO
harman results in decreased activity of MAOA protein
CTD
PMID:28057462
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression
ISO
harman results in increased expression of NFE2L2 protein
CTD
PMID:35985368
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
harman results in increased expression of NQO1 mRNA
CTD
PMID:35985368
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
harman results in increased cleavage of PARP1 protein
CTD
PMID:35985368
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
G
Slc22a1
solute carrier family 22 member 1
multiple interactions decreases activity
ISO
harman inhibits the reaction [SLC22A1 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] harman results in decreased activity of SLC22A1 protein
CTD
PMID:30189235
NCBI chr 1:50,624,339...50,651,437
Ensembl chr 1:50,624,377...50,651,436
G
Slc22a2
solute carrier family 22 member 2
decreases activity multiple interactions
ISO
harman results in decreased activity of SLC22A2 protein harman inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]
CTD
PMID:30189235
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
G
Taar1
trace-amine-associated receptor 1
increases activity multiple interactions
ISO
harman results in increased activity of TAAR1 protein [harman results in increased activity of TAAR1 protein] which results in increased abundance of Cyclic AMP
CTD
PMID:19725810
NCBI chr 1:23,336,978...23,337,976
Ensembl chr 1:23,335,165...23,353,981
G
Ache
acetylcholinesterase
decreases activity
ISO
Harmine results in decreased activity of ACHE protein
CTD
PMID:34078836
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
G
Adrb1
adrenoceptor beta 1
multiple interactions
ISO
Harmine affects the reaction [Epinephrine results in increased activity of ADRB1 protein]
CTD
PMID:30155694
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237
G
Adrb2
adrenoceptor beta 2
multiple interactions
ISO
Harmine inhibits the reaction [Epinephrine results in increased activity of ADRB2 protein]
CTD
PMID:30155694
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
Harmine inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]
CTD
PMID:22001777
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
G
Axin2
axin 2
multiple interactions
ISO
Harmine inhibits the reaction [WNT3A protein results in increased expression of AXIN2 mRNA]
CTD
PMID:20519739
NCBI chr10:94,393,379...94,426,579
Ensembl chr10:94,395,909...94,426,575
G
Bcl2l11
Bcl2-like 11
multiple interactions
ISO
Harmine promotes the reaction [Erlotinib Hydrochloride results in increased expression of BCL2L11 protein]
CTD
PMID:30171258
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695
G
Camk2d
calcium/calmodulin-dependent protein kinase II delta
decreases expression
EXP
harmine decreases expression of camk2d protein after myocardial infarction in rat heart left ventricle
RGD
PMID:26067684
RGD:11097969
NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:217,698,551...217,960,276
G
Ccna1
cyclin A1
increases expression
ISO
Harmine results in increased expression of CCNA1 mRNA; Harmine results in increased expression of CCNA1 protein
CTD
PMID:25751815
NCBI chr 2:141,383,352...141,428,205
Ensembl chr 2:141,382,468...141,393,300
G
Ccne2
cyclin E2
increases expression
ISO
Harmine results in increased expression of CCNE2 mRNA; Harmine results in increased expression of CCNE2 protein
CTD
PMID:25751815
NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:29,082,703...29,094,882
G
Cdc25a
cell division cycle 25A
increases expression
ISO
Harmine results in increased expression of CDC25A mRNA
CTD
PMID:25751815
NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:118,742,426...118,761,188
G
Cdc25c
cell division cycle 25C
increases expression
ISO
Harmine results in increased expression of CDC25C mRNA
CTD
PMID:25751815
NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292
G
Cdk1
cyclin-dependent kinase 1
increases expression
ISO
Harmine results in increased expression of CDK1 mRNA; Harmine results in increased expression of CDK1 protein
CTD
PMID:25751815
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
decreases phosphorylation
EXP
Harmine results in decreased phosphorylation of CDKN1B protein
CTD
PMID:26953159
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
decreases expression
ISO
Harmine results in decreased expression of CDKN1C mRNA; Harmine results in decreased expression of CDKN1C protein
CTD
PMID:25751815
NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
decreases expression
ISO
Harmine results in decreased expression of CDKN2A mRNA; Harmine results in decreased expression of CDKN2A protein
CTD
PMID:25751815
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
decreases expression
ISO
Harmine results in decreased expression of CDKN2B mRNA
CTD
PMID:25751815
NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855
G
Chd4
chromodomain helicase DNA binding protein 4
multiple interactions increases phosphorylation
ISO
AZD 6244 inhibits the reaction [Harmine results in increased phosphorylation of CHD4 protein]; Harmine inhibits the reaction [CHD4 protein affects the expression of UCP1 mRNA]; Harmine inhibits the reaction [CHD4 protein binds to UCP1 promoter]
CTD
PMID:27805061
NCBI chr 4:159,584,623...159,617,867
Ensembl chr 4:159,584,654...159,617,866
G
Cidea
cell death-inducing DFFA-like effector a
multiple interactions increases expression
ISO
Harmine affects the reaction [Dietary Fats affects the expression of CIDEA mRNA] Harmine results in increased expression of CIDEA protein
CTD
PMID:27805061
NCBI chr18:63,164,817...63,190,384
Ensembl chr18:63,164,099...63,190,382
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions decreases activity decreases stability
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Harmine results in decreased stability of CYP1A1 protein]; Harmine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Harmine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein] Harmine results in decreased activity of CYP1A1 protein
CTD
PMID:22001777
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Dio2
iodothyronine deiodinase 2
increases expression
ISO
Harmine results in increased expression of DIO2 protein
CTD
PMID:27805061
NCBI chr 6:115,396,308...115,410,594
Ensembl chr 6:115,396,308...115,410,594
G
Dyrk1a
dual specificity tyrosine phosphorylation regulated kinase 1A
multiple interactions decreases expression affects binding decreases activity
ISO EXP
Harmine inhibits the reaction [DYRK1A protein results in increased phosphorylation of MAPT protein] harmine decreases expression of dyrk1a protein after myocardial infarction in rat heart left ventricle Harmine binds to DYRK1A protein Harmine results in decreased activity of DYRK1A protein
CTD RGD
PMID:21573099 PMID:25751815 PMID:26067684
RGD:11097969
NCBI chr11:47,360,824...47,479,033
Ensembl chr11:47,360,850...47,479,033
G
E2f1
E2F transcription factor 1
increases expression
ISO
Harmine results in increased expression of E2F1 mRNA; Harmine results in increased expression of E2F1 protein
CTD
PMID:25751815
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563
G
E2f2
E2F transcription factor 2
increases expression
ISO
Harmine results in increased expression of E2F2 mRNA; Harmine results in increased expression of E2F2 protein
CTD
PMID:25751815
NCBI chr 5:153,682,789...153,706,087
Ensembl chr 5:153,682,789...153,706,087
G
E2f7
E2F transcription factor 7
increases expression
ISO
Harmine results in increased expression of E2F7 mRNA
CTD
PMID:25751815
NCBI chr 7:48,036,881...48,079,055
Ensembl chr 7:48,037,749...48,079,055
G
E2f8
E2F transcription factor 8
increases expression
ISO
Harmine results in increased expression of E2F8 mRNA
CTD
PMID:25751815
NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:107,701,985...107,720,009
G
Fabp4
fatty acid binding protein 4
multiple interactions
ISO
[phenylamil co-treated with Harmine] results in increased expression of FABP4 mRNA
CTD
PMID:20519739
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972
G
Foxm1
forkhead box M1
increases expression
ISO
Harmine results in increased expression of FOXM1 mRNA; Harmine results in increased expression of FOXM1 protein
CTD
PMID:25751815
NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:163,325,614...163,337,172
G
Id2
inhibitor of DNA binding 2
multiple interactions
ISO
Harmine inhibits the reaction [WNT3A protein results in decreased expression of ID2 mRNA]
CTD
PMID:20519739
NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:47,457,554...47,472,961
G
Ins1
insulin 1
multiple interactions
ISO
Harmine affects the reaction [LEPR protein affects the susceptibility to INS1 protein]
CTD
PMID:27805061
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
G
Ins2
insulin 2
increases expression
ISO
Harmine results in increased expression of INS mRNA
CTD
PMID:25751815
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
G
Lepr
leptin receptor
multiple interactions
ISO
Harmine affects the reaction [LEPR protein affects the susceptibility to INS1 protein]
CTD
PMID:27805061
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215
G
Mafa
MAF bZIP transcription factor A
increases expression
ISO
Harmine results in increased expression of MAFA mRNA; Harmine results in increased expression of MAFA protein
CTD
PMID:25751815
NCBI chr 7:109,313,021...109,315,813
Ensembl chr 7:109,313,121...109,315,760
G
Maoa
monoamine oxidase A
decreases activity
EXP ISO
Harmine results in decreased activity of MAOA protein
CTD
PMID:24373881 PMID:28302559
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation
ISO
Harmine results in increased phosphorylation of MAPK1 protein
CTD
PMID:27805061
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation
ISO
Harmine results in increased phosphorylation of MAPK3 protein
CTD
PMID:27805061
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
G
Mapt
microtubule-associated protein tau
multiple interactions
ISO
Harmine inhibits the reaction [DYRK1A protein results in increased phosphorylation of MAPT protein]
CTD
PMID:21573099
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
Harmine results in increased expression of MYC protein
CTD
PMID:25751815
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
G
Nfatc1
nuclear factor of activated T-cells 1
affects localization
ISO
Harmine affects the localization of NFATC1 protein
CTD
PMID:25751815
NCBI chr18:76,321,386...76,430,997
Ensembl chr18:76,321,386...76,430,990
G
Nfatc2
nuclear factor of activated T-cells 2
affects localization
ISO
Harmine affects the localization of NFATC2 protein
CTD
PMID:25751815
NCBI chr 3:177,615,189...177,747,493
Ensembl chr 3:177,618,314...177,747,380
G
Nfatc3
nuclear factor of activated T-cells 3
affects localization
ISO
Harmine affects the localization of NFATC3 protein
CTD
PMID:25751815
NCBI chr19:50,870,464...50,944,992
Ensembl chr19:50,870,489...50,944,992
G
Nfatc4
nuclear factor of activated T-cells 4
affects localization
ISO
Harmine affects the localization of NFATC4 protein
CTD
PMID:25751815
NCBI chr15:33,256,912...33,284,522
Ensembl chr15:33,274,153...33,285,582
G
Nkx6-1
NK6 homeobox 1
increases expression
ISO
Harmine results in increased expression of NKX6.1 mRNA; Harmine results in increased expression of NKX6.1 protein
CTD
PMID:25751815
NCBI chr14:8,274,238...8,281,171
Ensembl chr14:8,274,238...8,281,163
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
Harmine promotes the reaction [Erlotinib Hydrochloride results in increased cleavage of PARP1 protein]
CTD
PMID:30171258
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
G
Pdx1
pancreatic and duodenal homeobox 1
increases expression
ISO
Harmine results in increased expression of PDX1 mRNA; Harmine results in increased expression of PDX1 protein
CTD
PMID:25751815
NCBI chr12:12,793,957...12,799,156
Ensembl chr12:12,793,957...12,799,156
G
Pln
phospholamban
increases expression
EXP
harmine increases expression of Pln protein after myocardial infarction in rat heart left ventricle
RGD
PMID:26067684
RGD:11097969
NCBI chr20:33,166,512...33,182,241
Ensembl chr20:33,172,494...33,182,241
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases expression
ISO
[phenylamil co-treated with Harmine] results in increased expression of PPARG mRNA Harmine results in increased expression of PPARG protein
CTD
PMID:20519739 PMID:27805061
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
G
Ppargc1a
PPARG coactivator 1 alpha
increases expression multiple interactions
ISO
Harmine results in increased expression of PPARGC1A protein Harmine affects the reaction [Dietary Fats affects the expression of PPARGC1A mRNA]
CTD
PMID:27805061
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
G
Prdm16
PR/SET domain 16
increases expression multiple interactions
ISO
Harmine results in increased expression of PRDM16 protein Harmine affects the reaction [Dietary Fats affects the expression of PRDM16 mRNA]
CTD
PMID:27805061
NCBI chr 5:170,162,275...170,486,371
Ensembl chr 5:170,162,275...170,485,804
G
Ucp1
uncoupling protein 1
increases expression multiple interactions
ISO
Harmine results in increased expression of UCP1 mRNA; Harmine results in increased expression of UCP1 protein 2-chloro-5-nitrobenzanilide inhibits the reaction [Harmine results in increased expression of UCP1 mRNA]; AZD 6244 inhibits the reaction [Harmine results in increased expression of UCP1 mRNA]; Harmine affects the reaction [Dietary Fats affects the expression of UCP1 mRNA]; Harmine inhibits the reaction [CHD4 protein affects the expression of UCP1 mRNA]; Harmine inhibits the reaction [CHD4 protein binds to UCP1 promoter]; N4-(9-ethyl-9H-carbazol-3-yl)-N2-(3-morpholin-4-ylpropyl)-pyrimidine-2,4-diamine inhibits the reaction [Harmine results in increased expression of UCP1 mRNA]
CTD
PMID:27805061
NCBI chr19:41,713,350...41,721,421
Ensembl chr19:41,713,351...41,721,420
G
Wnt3a
Wnt family member 3A
multiple interactions
ISO
Harmine inhibits the reaction [WNT3A protein results in decreased expression of ID2 mRNA]; Harmine inhibits the reaction [WNT3A protein results in increased expression of AXIN2 mRNA]
CTD
PMID:20519739
NCBI chr10:44,533,734...44,577,919
Ensembl chr10:44,533,734...44,577,919
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
harmol inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]
CTD
PMID:22001777
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions decreases activity decreases stability
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [harmol results in decreased stability of CYP1A1 protein]; harmol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; harmol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein] harmol results in decreased activity of CYP1A1 protein
CTD
PMID:22001777
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Sult1a1
sulfotransferase family 1A member 1
multiple interactions
EXP ISO
Mefenamic Acid inhibits the reaction [SULT1A1 protein results in increased sulfation of harmol]
CTD
PMID:11181495
NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131
G
Acta2
actin alpha 2, smooth muscle
decreases expression
ISO
rutecarpine results in decreased expression of ACTA2 mRNA
CTD
PMID:34955744
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
G
Ada
adenosine deaminase
decreases expression
ISO
rutecarpine results in decreased expression of ADA mRNA
CTD
PMID:34955744
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293
G
Ahr
aryl hydrocarbon receptor
increases localization increases expression multiple interactions affects binding
ISO EXP
rutecarpine results in increased localization of AHR protein rutecarpine results in increased expression of AHR mRNA 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [rutecarpine results in increased localization of AHR protein]; AHR affects the reaction [rutecarpine results in increased activity of and results in increased expression of CYP1A1 protein]; AHR affects the reaction [rutecarpine results in increased expression of CYP1A1 mRNA]; rutecarpine promotes the reaction [AHR protein binds to CYP1A1 promoter]; W 7 inhibits the reaction [rutecarpine results in increased localization of AHR protein] 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [rutecarpine binds to AHR protein]; rutecarpine inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]; W 7 inhibits the reaction [rutecarpine binds to AHR protein]
CTD
PMID:19853001 PMID:20449727
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
G
Ahrr
aryl-hydrocarbon receptor repressor
increases expression
ISO
rutecarpine results in increased expression of AHRR mRNA
CTD
PMID:20449727
NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866
G
Amotl2
angiomotin like 2
decreases expression
ISO
rutecarpine results in decreased expression of AMOTL2 mRNA
CTD
PMID:34955744
NCBI chr 8:112,182,060...112,198,032
Ensembl chr 8:112,181,863...112,198,030
G
Angpt1
angiopoietin 1
decreases expression
ISO
rutecarpine results in decreased expression of ANGPT1 mRNA
CTD
PMID:34955744
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696
G
Anln
anillin, actin binding protein
decreases expression
ISO
rutecarpine results in decreased expression of ANLN mRNA
CTD
PMID:34955744
NCBI chr 8:29,134,222...29,197,513
Ensembl chr 8:29,134,222...29,197,513
G
Arhgef39
Rho guanine nucleotide exchange factor 39
decreases expression
ISO
rutecarpine results in decreased expression of ARHGEF39 mRNA
CTD
PMID:34955744
NCBI chr 5:62,548,300...62,551,870
Ensembl chr 5:62,548,303...62,551,870
G
Astn2
astrotactin 2
decreases expression
ISO
rutecarpine results in decreased expression of ASTN2 mRNA
CTD
PMID:34955744
NCBI chr 5:83,772,988...84,759,439
Ensembl chr 5:83,773,633...84,759,485
G
Bex4
brain expressed, X-linked 4
increases expression
ISO
rutecarpine results in increased expression of BEX4 mRNA
CTD
PMID:34955744
NCBI chr X:103,923,609...103,925,041
Ensembl chr X:103,923,338...103,925,496
G
Bmpr1a
bone morphogenetic protein receptor type 1A
decreases expression
ISO
rutecarpine results in decreased expression of BMPR1A mRNA
CTD
PMID:25633564
NCBI chr16:9,740,751...9,786,861
Ensembl chr16:9,742,875...9,786,861
G
Bmpr1b
bone morphogenetic protein receptor type 1B
decreases expression
ISO
rutecarpine results in decreased expression of BMPR1B mRNA
CTD
PMID:25633564
NCBI chr 2:233,211,525...233,544,344
Ensembl chr 2:233,211,525...233,544,311
G
Bmpr2
bone morphogenetic protein receptor type 2
decreases expression
ISO
rutecarpine results in decreased expression of BMPR2 mRNA
CTD
PMID:25633564
NCBI chr 9:68,685,942...68,801,353
Ensembl chr 9:68,685,988...68,801,350
G
Camk1
calcium/calmodulin-dependent protein kinase I
increases phosphorylation
ISO
rutecarpine results in increased phosphorylation of CAMK1 protein
CTD
PMID:19853001
NCBI chr 4:148,036,843...148,047,675
Ensembl chr 4:148,036,824...148,047,245
G
Card10
caspase recruitment domain family, member 10
increases expression
ISO
rutecarpine results in increased expression of CARD10 mRNA
CTD
PMID:34955744
NCBI chr 7:112,210,944...112,252,044
Ensembl chr 7:112,210,776...112,239,806
G
Casp3
caspase 3
multiple interactions
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; KN 93 inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; rutecarpine inhibits the reaction [Glucose results in increased activity of CASP3 protein]; rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; zinc protoporphyrin inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]
CTD
PMID:28025122 PMID:36928891
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Ccl20
C-C motif chemokine ligand 20
increases expression
ISO
rutecarpine results in increased expression of CCL20 mRNA
CTD
PMID:34955744
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736
G
Ccn2
cellular communication network factor 2
decreases expression
ISO
rutecarpine results in decreased expression of CCN2 mRNA
CTD
PMID:34955744
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976
G
Cd24
CD24 molecule
decreases expression
ISO
rutecarpine results in decreased expression of CD24 mRNA
CTD
PMID:34955744
NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785
G
Cdk1
cyclin-dependent kinase 1
decreases expression
ISO
rutecarpine results in decreased expression of CDK1 mRNA
CTD
PMID:34955744
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
G
Cemip2
cell migration inducing hyaluronidase 2
increases expression
ISO
rutecarpine results in increased expression of CEMIP2 mRNA
CTD
PMID:34955744
NCBI chr 1:228,756,826...228,834,313
Ensembl chr 1:228,757,466...228,832,906
G
Col1a1
collagen type I alpha 1 chain
decreases expression
ISO
rutecarpine results in decreased expression of COL1A1 mRNA
CTD
PMID:34955744
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
G
Col1a2
collagen type I alpha 2 chain
decreases expression
ISO
rutecarpine results in decreased expression of COL1A2 mRNA
CTD
PMID:34955744
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995
G
Coro1a
coronin 1A
decreases expression
ISO
rutecarpine results in decreased expression of CORO1A mRNA
CTD
PMID:34955744
NCBI chr 1:190,726,129...190,731,133
Ensembl chr 1:190,726,130...190,731,102
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression affects binding
ISO EXP
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [rutecarpine results in increased activity of and results in increased expression of CYP1A1 protein]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [rutecarpine results in increased expression of CYP1A1 mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [rutecarpine results in increased activity of and results in increased expression of CYP1A1 protein]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [rutecarpine results in increased expression of CYP1A1 mRNA]; AHR affects the reaction [rutecarpine results in increased activity of and results in increased expression of CYP1A1 protein]; AHR affects the reaction [rutecarpine results in increased expression of CYP1A1 mRNA]; capsazepine inhibits the reaction [rutecarpine results in increased activity of and results in increased expression of CYP1A1 protein]; capsazepine inhibits the reaction [rutecarpine results in increased expression of CYP1A1 mRNA]; rutecarpine promotes the reaction [AHR protein binds to CYP1A1 promoter]; rutecarpine results in increased activity of and results in increased expression of CYP1A1 protein; W 7 inhibits the reaction [rutecarpine results in increased activity of and results in increased expression of CYP1A1 protein]; W 7 inhibits the reaction [rutecarpine results in increased expression of CYP1A1 mRNA] 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [rutecarpine binds to CYP1A1 promoter]; W 7 inhibits the reaction [rutecarpine binds to CYP1A1 promoter]
CTD
PMID:19853001 PMID:20449727
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions increases activity
EXP ISO
rutecarpine promotes the reaction [CYP1A2 protein affects the metabolism of Theophylline] rutecarpine analog binds to and results in decreased activity of CYP1A2 protein; rutecarpine binds to and results in decreased activity of CYP1A2 protein rutecarpine results in increased activity of CYP1A2 protein
CTD
PMID:12852960 PMID:15720787
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions increases expression
ISO
rutecarpine analog binds to and results in decreased activity of CYP1B1 protein rutecarpine results in increased expression of CYP1B1 mRNA
CTD
PMID:12852960 PMID:34955744
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
G
Dcc
DCC netrin 1 receptor
decreases expression
ISO
rutecarpine results in decreased expression of DCC mRNA
CTD
PMID:34955744
NCBI chr18:67,144,272...68,248,159
Ensembl chr18:67,149,179...68,247,541
G
Dnai3
dynein axonemal intermediate chain 3
decreases expression
ISO
rutecarpine results in decreased expression of WDR63 mRNA
CTD
PMID:34955744
NCBI chr 2:237,608,202...237,666,465
Ensembl chr 2:237,604,068...237,666,465
G
Efemp1
EGF containing fibulin extracellular matrix protein 1
decreases expression
ISO
rutecarpine results in decreased expression of EFEMP1 mRNA
CTD
PMID:34955744
NCBI chr14:106,811,769...106,890,961
Ensembl chr14:106,802,304...106,892,808
G
Epha2
Eph receptor A2
decreases expression
ISO
rutecarpine results in decreased expression of EPHA2 mRNA
CTD
PMID:34955744
NCBI chr 5:158,888,629...158,917,100
Ensembl chr 5:158,888,629...158,917,234
G
F3
coagulation factor III, tissue factor
increases expression
ISO
rutecarpine results in increased expression of F3 mRNA
CTD
PMID:34955744
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369
G
Fam83d
family with sequence similarity 83, member D
decreases expression
ISO
rutecarpine results in decreased expression of FAM83D mRNA
CTD
PMID:34955744
NCBI chr 3:167,841,748...167,861,062
Ensembl chr 3:167,841,791...167,861,061
G
Fbxo5
F-box protein 5
decreases expression
ISO
rutecarpine results in decreased expression of FBXO5 mRNA
CTD
PMID:34955744
NCBI chr 1:44,601,412...44,607,781
Ensembl chr 1:44,601,412...44,607,781
G
Fermt1
FERM domain containing kindlin 1
decreases expression
ISO
rutecarpine results in decreased expression of FERMT1 mRNA
CTD
PMID:34955744
NCBI chr 3:140,624,434...140,666,419
Ensembl chr 3:140,624,434...140,666,419
G
Fgf2
fibroblast growth factor 2
increases expression
ISO
rutecarpine results in increased expression of FGF2 mRNA
CTD
PMID:34955744
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
G
Fgf7
fibroblast growth factor 7
decreases expression
ISO
rutecarpine results in decreased expression of FGF7 mRNA
CTD
PMID:34955744
NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:133,734,673...133,786,328
G
Foxg1
forkhead box G1
decreases expression
ISO
rutecarpine results in decreased expression of FOXG1 mRNA
CTD
PMID:34955744
NCBI chr 6:72,401,582...72,404,392
Ensembl chr 6:72,394,239...72,427,392
G
Frmd5
FERM domain containing 5
decreases expression
ISO
rutecarpine results in decreased expression of FRMD5 mRNA
CTD
PMID:34955744
NCBI chr 3:128,945,812...129,217,134
Ensembl chr 3:128,927,671...129,217,074
G
Furin
furin (paired basic amino acid cleaving enzyme)
decreases expression
ISO
rutecarpine results in decreased expression of FURIN mRNA
CTD
PMID:25633564
NCBI chr 1:143,757,389...143,770,430
Ensembl chr 1:143,757,391...143,773,497
G
Gpnmb
glycoprotein nmb
decreases expression
ISO
rutecarpine results in decreased expression of GPNMB mRNA
CTD
PMID:34955744
NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
ISO
rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]
CTD
PMID:28025122
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
G
Grem1
gremlin 1, DAN family BMP antagonist
increases expression
ISO
rutecarpine results in increased expression of GREM1 mRNA
CTD
PMID:34955744
NCBI chr 3:120,966,639...120,978,319
Ensembl chr 3:120,966,623...120,979,089
G
Gtse1
G-2 and S-phase expressed 1
decreases expression
ISO
rutecarpine results in decreased expression of GTSE1 mRNA
CTD
PMID:34955744
NCBI chr 7:118,829,793...118,846,662
Ensembl chr 7:118,829,903...118,846,661
G
Hamp
hepcidin antimicrobial peptide
multiple interactions decreases expression
ISO
rutecarpine inhibits the reaction [IL6 protein results in increased expression of HAMP mRNA] rutecarpine results in decreased expression of HAMP mRNA
CTD
PMID:25633564
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297
G
Has2
hyaluronan synthase 2
increases expression
ISO
rutecarpine results in increased expression of HAS2 mRNA
CTD
PMID:34955744
NCBI chr 7:90,002,929...90,028,933
Ensembl chr 7:90,002,929...90,018,535
G
Hjv
hemojuvelin BMP co-receptor
decreases expression
ISO
rutecarpine results in decreased expression of HJV mRNA
CTD
PMID:25633564
NCBI chr 2:186,754,801...186,758,708
Ensembl chr 2:186,754,811...186,758,867
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]
CTD
PMID:28025122
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
ISO
rutecarpine results in increased expression of HSPA5 mRNA
CTD
PMID:34955744
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
G
Icam1
intercellular adhesion molecule 1
increases expression
ISO
rutecarpine results in increased expression of ICAM1 mRNA
CTD
PMID:34955744
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
G
Id1
inhibitor of DNA binding 1
decreases expression
ISO
rutecarpine results in decreased expression of ID1 mRNA
CTD
PMID:34955744
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685
G
Igfbp3
insulin-like growth factor binding protein 3
increases expression
ISO
rutecarpine results in increased expression of IGFBP3 mRNA
CTD
PMID:34955744
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944
G
Igfbp5
insulin-like growth factor binding protein 5
decreases expression
ISO
rutecarpine results in decreased expression of IGFBP5 mRNA
CTD
PMID:34955744
NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390
G
Il1b
interleukin 1 beta
multiple interactions increases expression
ISO
Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased expression of IL1B protein]]; rutecarpine inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; rutecarpine inhibits the reaction [Glucose results in increased expression of IL1B protein] rutecarpine results in increased expression of IL1B mRNA
CTD
PMID:34955744 PMID:36928891
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Il24
interleukin 24
increases expression
ISO
rutecarpine results in increased expression of IL24 mRNA
CTD
PMID:34955744
NCBI chr13:44,905,362...44,910,760
Ensembl chr13:44,905,363...44,910,760
G
Il6
interleukin 6
multiple interactions
ISO
Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased expression of IL6 protein]]; rutecarpine inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; rutecarpine inhibits the reaction [Glucose results in increased expression of IL6 protein]; rutecarpine inhibits the reaction [IL6 protein results in increased expression of HAMP mRNA]
CTD
PMID:25633564 PMID:36928891
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
G
Irs2
insulin receptor substrate 2
increases expression
ISO
rutecarpine results in increased expression of IRS2 mRNA
CTD
PMID:34955744
NCBI chr16:85,190,310...85,214,543
Ensembl chr16:85,190,111...85,214,543
G
Itga11
integrin subunit alpha 11
increases expression
ISO
rutecarpine results in increased expression of ITGA11 mRNA
CTD
PMID:34955744
NCBI chr 8:72,041,432...72,150,137
Ensembl chr 8:72,016,652...72,150,137
G
Itga2
integrin subunit alpha 2
increases expression
ISO
rutecarpine results in increased expression of ITGA2 mRNA
CTD
PMID:34955744
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:48,253,412...48,354,509
G
Itgb3
integrin subunit beta 3
increases expression
ISO
rutecarpine results in increased expression of ITGB3 mRNA
CTD
PMID:34955744
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:90,009,900...90,067,800
G
Itgb8
integrin subunit beta 8
increases expression
ISO
rutecarpine results in increased expression of ITGB8 mRNA
CTD
PMID:34955744
NCBI chr 6:146,267,982...146,351,245
Ensembl chr 6:146,165,484...146,351,245
G
Kank1
KN motif and ankyrin repeat domains 1
decreases expression
ISO
rutecarpine results in decreased expression of KANK1 mRNA
CTD
PMID:34955744
NCBI chr 1:232,381,720...232,500,834
Ensembl chr 1:232,445,658...232,500,839
G
Lama4
laminin subunit alpha 4
decreases expression
ISO
rutecarpine results in decreased expression of LAMA4 mRNA
CTD
PMID:34955744
NCBI chr20:43,946,898...44,087,972
Ensembl chr20:43,946,898...44,087,972
G
Lpxn
leupaxin
increases expression
ISO
rutecarpine results in increased expression of LPXN mRNA
CTD
PMID:34955744
NCBI chr 1:219,353,319...219,387,743
Ensembl chr 1:219,353,708...219,387,742
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
ISO
Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased phosphorylation of MAPK8 protein]]; rutecarpine inhibits the reaction [Glucose results in increased phosphorylation of MAPK8 protein]
CTD
PMID:36928891
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
G
Matn2
matrilin 2
decreases expression
ISO
rutecarpine results in decreased expression of MATN2 mRNA
CTD
PMID:34955744
NCBI chr 7:67,380,140...67,529,767
Ensembl chr 7:67,380,168...67,530,153
G
Mmp1
matrix metallopeptidase 1
increases expression
ISO
rutecarpine results in increased expression of MMP1 mRNA
CTD
PMID:34955744
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
G
Mmp14
matrix metallopeptidase 14
increases expression
ISO
rutecarpine results in increased expression of MMP14 mRNA
CTD
PMID:34955744
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893
G
Mylk
myosin light chain kinase
decreases expression
ISO
rutecarpine results in decreased expression of MYLK mRNA
CTD
PMID:34955744
NCBI chr11:79,288,243...79,535,450
Ensembl chr11:79,288,243...79,535,659
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression
ISO
rutecarpine results in increased expression of NFE2L2 mRNA
CTD
PMID:34955744
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
rutecarpine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD
PMID:17109845
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 protein]
CTD
PMID:28025122
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
G
Nr2f1
nuclear receptor subfamily 2, group F, member 1
decreases expression
ISO
rutecarpine results in decreased expression of NR2F1 mRNA
CTD
PMID:34955744
NCBI chr 2:9,776,179...9,785,924
Ensembl chr 2:9,776,179...9,785,924
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
decreases expression
ISO
rutecarpine results in decreased expression of NR4A2 mRNA
CTD
PMID:34955744
NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:62,098,743...62,106,769
G
Ntn4
netrin 4
increases expression
ISO
rutecarpine results in increased expression of NTN4 mRNA
CTD
PMID:34955744
NCBI chr 7:30,073,637...30,187,407
Ensembl chr 7:30,073,333...30,188,309
G
Ntng1
netrin G1
decreases expression
ISO
rutecarpine results in decreased expression of NTNG1 mRNA
CTD
PMID:34955744
NCBI chr 2:200,151,979...200,515,031
Ensembl chr 2:200,151,979...200,515,031
G
Plk2
polo-like kinase 2
decreases expression
ISO
rutecarpine results in decreased expression of PLK2 mRNA
CTD
PMID:34955744
NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296
G
Ppargc1a
PPARG coactivator 1 alpha
decreases expression
ISO
rutecarpine results in decreased expression of PPARGC1A mRNA
CTD
PMID:34955744
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
G
Prag1
PEAK1 related kinase activating pseudokinase 1
decreases expression
ISO
rutecarpine results in decreased expression of PRAG1 mRNA
CTD
PMID:34955744
NCBI chr16:62,791,249...62,844,532
Ensembl chr16:62,786,329...62,844,532
G
Prr5l
proline rich 5 like
decreases expression
ISO
rutecarpine results in decreased expression of PRR5L mRNA
CTD
PMID:34955744
NCBI chr 3:108,458,107...108,628,552
Ensembl chr 3:108,458,633...108,537,763
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
rutecarpine results in increased expression of PTGS2 mRNA
CTD
PMID:34955744
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
G
Ptn
pleiotrophin
decreases expression
ISO
rutecarpine results in decreased expression of PTN mRNA
CTD
PMID:34955744
NCBI chr 4:66,260,764...66,342,614
Ensembl chr 4:66,260,764...66,342,482
G
Scg2
secretogranin II
decreases expression
ISO
rutecarpine results in decreased expression of SCG2 mRNA
CTD
PMID:34955744
NCBI chr 9:88,251,531...88,257,208
Ensembl chr 9:88,251,354...88,269,598
G
Sdc1
syndecan 1
decreases expression
ISO
rutecarpine results in decreased expression of SDC1 mRNA
CTD
PMID:34955744
NCBI chr 6:37,282,041...37,304,503
Ensembl chr 6:37,297,010...37,304,500
G
Sfrp2
secreted frizzled-related protein 2
increases expression
ISO
rutecarpine results in increased expression of SFRP2 mRNA
CTD
PMID:34955744
NCBI chr 2:171,387,536...171,395,081
Ensembl chr 2:171,387,385...171,395,079
G
Slc3a2
solute carrier family 3 member 2
increases expression
ISO
rutecarpine results in increased expression of SLC3A2 mRNA
CTD
PMID:34955744
NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:215,033,601...215,048,064
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
rutecarpine results in increased expression of SLC7A11 mRNA
CTD
PMID:34955744
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
G
Slc7a5
solute carrier family 7 member 5
increases expression
ISO
rutecarpine results in increased expression of SLC7A5 mRNA
CTD
PMID:34955744
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:66,843,808...66,872,412
G
Spry2
sprouty RTK signaling antagonist 2
increases expression
ISO
rutecarpine results in increased expression of SPRY2 mRNA
CTD
PMID:34955744
NCBI chr15:89,106,809...89,111,926
Ensembl chr15:89,103,731...89,115,074
G
Srgap3
SLIT-ROBO Rho GTPase activating protein 3
increases expression
ISO
rutecarpine results in increased expression of SRGAP3 mRNA
CTD
PMID:34955744
NCBI chr 4:147,391,082...147,626,407
Ensembl chr 4:147,395,880...147,625,713
G
Srpx2
sushi-repeat-containing protein, X-linked 2
decreases expression
ISO
rutecarpine results in decreased expression of SRPX2 mRNA
CTD
PMID:34955744
NCBI chr X:101,399,748...101,425,486
Ensembl chr X:101,399,853...101,425,484
G
Ssh1
slingshot protein phosphatase 1
increases expression
ISO
rutecarpine results in increased expression of SSH1 mRNA
CTD
PMID:34955744
NCBI chr12:48,281,756...48,343,812
Ensembl chr12:48,281,756...48,343,812
G
Thbs1
thrombospondin 1
increases expression
ISO
rutecarpine results in increased expression of THBS1 mRNA
CTD
PMID:34955744
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402
G
Tmeff2
transmembrane protein with EGF-like and two follistatin-like domains 2
decreases expression
ISO
rutecarpine results in decreased expression of TMEFF2 mRNA
CTD
PMID:34955744
NCBI chr 9:57,937,873...58,225,372
Ensembl chr 9:57,937,873...58,225,372
G
Tmsb4x
thymosin beta 4, X-linked
decreases expression
ISO
rutecarpine results in decreased expression of TMSB4X mRNA
CTD
PMID:34955744
NCBI chr X:30,761,611...30,763,612
Ensembl chr X:30,761,612...30,763,613
G
Tnf
tumor necrosis factor
multiple interactions decreases secretion
ISO
Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased expression of TNF protein]]; rutecarpine inhibits the reaction [Glucose results in increased expression of TNF mRNA]; rutecarpine inhibits the reaction [Glucose results in increased expression of TNF protein] rutecarpine results in decreased secretion of TNF protein
CTD
PMID:36928891 PMID:38041080
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
Vcam1
vascular cell adhesion molecule 1
decreases expression
ISO
rutecarpine results in decreased expression of VCAM1 mRNA
CTD
PMID:34955744
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
G
Wnt5a
Wnt family member 5A
increases expression
ISO
rutecarpine results in increased expression of WNT5A mRNA
CTD
PMID:34955744
NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,703,665...3,724,860
G
Wnt5b
Wnt family member 5B
decreases expression
ISO
rutecarpine results in decreased expression of WNT5B mRNA
CTD
PMID:34955744
NCBI chr 4:154,281,852...154,406,081
Ensembl chr 4:154,281,852...154,405,681
G
Wwc1
WW and C2 domain containing 1
decreases expression
ISO
rutecarpine results in decreased expression of WWC1 mRNA
CTD
PMID:34955744
NCBI chr10:20,804,173...20,958,437
Ensembl chr10:20,799,237...20,958,437
G
Cd274
CD274 molecule
decreases expression
ISO
tubastatin A results in decreased expression of CD274 protein
CTD
PMID:26775640
NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:236,496,463...236,549,951
G
Hdac6
histone deacetylase 6
multiple interactions decreases activity
ISO
tubastatin A inhibits the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of HDAC6 protein]; tubastatin A inhibits the reaction [bisphenol A results in increased expression of HDAC6 protein] tubastatin A results in decreased activity of HDAC6 protein
CTD
PMID:26775640 PMID:34910997
NCBI chr X:17,222,538...17,244,373
Ensembl chr X:17,222,856...17,244,370
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions
ISO
tubastatin A inhibits the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of MYC protein]; tubastatin A inhibits the reaction [bisphenol A results in increased expression of MYC protein]
CTD
PMID:34910997
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
tubastatin A inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein]
CTD
PMID:22367689
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
G
Pdk1
pyruvate dehydrogenase kinase 1
multiple interactions
ISO
tubastatin A affects the reaction [PDK1 protein affects the abundance of Cyclic AMP]
CTD
PMID:28887310
NCBI chr 3:77,113,464...77,144,145
Ensembl chr 3:77,113,473...77,144,145
G
Pten
phosphatase and tensin homolog
increases expression multiple interactions
ISO
tubastatin A results in increased expression of PTEN mRNA [bisphenol A co-treated with tubastatin A] results in increased expression of PTEN mRNA; [mono-(2-ethylhexyl)phthalate co-treated with bisphenol A co-treated with tubastatin A] results in increased expression of PTEN mRNA; [mono-(2-ethylhexyl)phthalate co-treated with tubastatin A] results in increased expression of PTEN mRNA
CTD
PMID:34910997
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330
G
Stat3
signal transducer and activator of transcription 3
decreases phosphorylation
ISO
tubastatin A results in decreased phosphorylation of STAT3 protein
CTD
PMID:26775640
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
20862
chemical entity
20860
atom
20860
nonmetal atom
20766
nitrogen atom
19595
nitrogen molecular entity
19595
organonitrogen compound
19403
organonitrogen heterocyclic compound
18546
pyridoindole
550
(14E)-11-Hydroxy-14-(1H-imidazol-5-ylmethylidene)-2-methoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione
0
14-epi-isochaetominine C
0
2,11-dimethoxy-9-(2-methylbut-3-en-2-yl)-14-propan-2-yl-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione
0
2-Amino-3-methyl-9H-pyrido[2,3-b]indole
10
2-Amino-9H-pyrido[2,3-b]indole
10
2-amino-9-ethyl-3-pyrido[2,3-b]indolecarboxylic acid ethyl ester
0
3-Amino-1-methyl-5H-pyrido[4,3-b]indole
20
5H-Pyrido[4,3-b]indole
0
9H-Pyrido[2,3-b]indole
0
Aniquinazoline D
0
Commnesin 470
0
Communesin A
0
Communesin B
0
Communesin C
0
Communesin D
0
Communesin E
0
Communesin F
0
Communesin G
0
Communesin H
0
Communesin I
0
Communesin J
0
Communesin K
0
Epi-neoxaline
0
Isochaetominine
0
Isochaetominine A
0
Isochaetominine B
0
Isochaetominine C
0
Isopropylchaetominine
0
Meleagrin C
0
Meleagrin D
0
Meleagrin E
0
Mescengricin
0
Neosartin C
0
Neoxaline
0
Sphecoline A
0
Sphecoline E
0
Sphecoline F
0
Sphecoline G
0
Trp-P-1
0
Versiquinazoline H
0
Versiquinazoline J
0
Versiquinazoline K
0
Versiquinazoline Q
0
alosetron +
0
beta-carbolines +
536
intoplicine
0
latrepirdine
0
pyridoindolecarboxamide +
0
tubastatin A
7
Path 2
CHEBI ontology
20862
subatomic particle
20860
composite particle
20860
hadron
20860
baryon
20860
nucleon
20860
atomic nucleus
20860
atom
20860
main group element atom
20781
p-block element atom
20781
carbon group element atom
20715
carbon atom
20710
organic molecular entity
20710
organic molecule
20654
organic cyclic compound
20404
organic heterocyclic compound
19388
organic heteropolycyclic compound
18651
organic heterotricyclic compound
16078
pyridoindole
550
(14E)-11-Hydroxy-14-(1H-imidazol-5-ylmethylidene)-2-methoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione
0
14-epi-isochaetominine C
0
2,11-dimethoxy-9-(2-methylbut-3-en-2-yl)-14-propan-2-yl-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione
0
2-Amino-3-methyl-9H-pyrido[2,3-b]indole
10
2-Amino-9H-pyrido[2,3-b]indole
10
2-amino-9-ethyl-3-pyrido[2,3-b]indolecarboxylic acid ethyl ester
0
3-Amino-1-methyl-5H-pyrido[4,3-b]indole
20
5H-Pyrido[4,3-b]indole
0
9H-Pyrido[2,3-b]indole
0
Aniquinazoline D
0
Commnesin 470
0
Communesin A
0
Communesin B
0
Communesin C
0
Communesin D
0
Communesin E
0
Communesin F
0
Communesin G
0
Communesin H
0
Communesin I
0
Communesin J
0
Communesin K
0
Epi-neoxaline
0
Isochaetominine
0
Isochaetominine A
0
Isochaetominine B
0
Isochaetominine C
0
Isopropylchaetominine
0
Meleagrin C
0
Meleagrin D
0
Meleagrin E
0
Mescengricin
0
Neosartin C
0
Neoxaline
0
Sphecoline A
0
Sphecoline E
0
Sphecoline F
0
Sphecoline G
0
Trp-P-1
0
Versiquinazoline H
0
Versiquinazoline J
0
Versiquinazoline K
0
Versiquinazoline Q
0
alosetron +
0
beta-carbolines +
536
intoplicine
0
latrepirdine
0
pyridoindolecarboxamide +
0
tubastatin A
7